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ABSTRACT 
Due to their broad applications in the field of polymers, cosmetics, nutraceuticals 
and pharmaceuticals, aromatic compounds have garnered multitudinous attentions. 
Microbial production of aromatic compounds from simple building blocks serves as a 
promising approach toward sustainable and scalable production of value-added 
chemicals. Owning to its well understood physiology, metabolism, and genetics, ease of 
manipulation, and capability of functionally expressing challenging endoplasmic 
reticulum-associated P450s, Saccharomyces cerevisiae has been overwhelmingly 
employed for the production of aromatic compounds, especially those plant sourced 
aromatic natural products with complex structures, albeit at low titers. Although 
numerous endeavors have been devoted to enhancing the production of aromatic 
compounds in S. cerevisiae, the final titers remain low and need further improvement for 
industrial commercialization. The insufficient production is ascribed to two aspects: one 
is limited precursor availability caused by tight regulations imposed on central 
metabolism and the other is the stepwise loss resulted from non-balanced and low 
throughput metabolic pathways.  
Looking beyond S. cerevisiae, many non-conventional yeasts possess highly 
desirable traits that are obtained through long term evolution in particular environment 
but challenging to be horizontally transferred to model hosts without compromise. 
However, due to the lack of the available synthetic biology elements (e.g., promoters, 
terminators, and vectors) and efficient genome editing method, a majority of the 




Scheffersomyces stipitis natively assimilates xylose that can be integrated into central 
metabolism exclusively through pentose phosphate pathway; thus S. stipitis has evolved 
highly active pentose phosphate pathway, which would be beneficial for providing the 
precursor, erythrose-4-phosphate, for the first committed step of the biosynthesis of 
aromatic compounds. Transcriptomic analysis of S. stipitis grown in various sugar-
containing cultures facilitated the discovery of strong and constitutive promoters and 
terminators, and the identification of the rate-limiting steps in mixed-sugar utilization. 
The constitutive expression of genes involved in intracellular xylose metabolization 
together with a novel xylose-specific transporter that is free from glucose inhibition 
resulted in efficient simultaneous mixed-sugar utilization in S. stipitis. Further 
introduction of a minimal shikimate-accumulating pathway resulted in the highest 
shikimate titer (4.5 g/L) and yield (90.5 mg/g sugar) ever reported in yeasts. Synthetic 
yeast consortia were developed for the production of precursors of benzyisoquinoline 
alkaloids by leveraging the active upstream module from S. stipitis and the extensively 
optimized downstream module in S. cerevisiae. The transfer of the connecting molecule, 
shikimate, in the yeast consortia was empowered by two novel shikimate transporters. 
Through independently optimizing the two modules and tuning the cell ratio of the two 
specialists, the final titer of the exemplary molecule, norcoclaurine, was 1,015 μg/L, 10 
times higher than the highest titer achieved in S. cerevisiae monoculture. Future efforts 
should focus on ameliorating both upstream and downstream modules of the yeast 




CHAPTER 1 INTRODUCTION 
1.1 Motivations 
Due to the unsustainability of petroleum-derived chemicals and the food vs. fuel 
dilemma of first-generation biofuel, lignocellulosic biomass serves as a promising 
alternative feedstock for the industrial large-scale production of value-added compounds. 
Regardless of its recalcitrance, lignocellulosic biomass is sustainable, abundant, cheap, 
and worldwide available. Meanwhile, the consumption of this feedstock eliminates 
serious environmental problems caused by its over accumulation. To economically 
compete with the petroleum counterpart, the production of value-added chemicals, 
especially those with marginal profit, from biomass hydrolysates requires the 
simultaneous utilization of all sugars.  
Aromatic compounds are an enormous group of compounds that have broad 
applications in the fields of polymers, cosmetics, nutraceuticals and pharmaceuticals with 
substantial commercial value. Regardless of their vast chemical diversity, aromatic 
compounds in plants are at low abundance and in the mixture with many other 
structurally similar compounds making the crop-base extraction process cumbersome and 
costly. Some plants of interest are hard to cultivate or even endangered in nature. 
Meanwhile, the complex structures of plant-sourced aromatic chemicals impede the 
development of efficient chemical synthesis. Accordingly, researchers have focused on 
developing efficient microbial synthetic platforms for the economic production of 




Current microbial production of aromatic compounds is mostly restricted to 
model hosts, such as Escherichia coli and Saccharomyces cerevisiae, with special 
emphasis on the latter ascribed to its amenability to the functional expression of 
endoplasmic reticulum-associated cytochrome P450s and complex post-translational 
modifications. As a result, the de novo production of a wide array of high-value aromatic 
chemicals (e.g., muconic acid, shikimic acid, naringenin, resveratrol, hydrocodone, and 
thebaine) was successfully achieved in S. cerevisiae, albeit at low levels. Numerous 
endeavors have been attributed to improving the production of aromatic compounds in 
the model host. Beside common strategies, like elimination of feedback inhibitions, 
increase of precursor availability, and removal of competing pathways, novel approaches 
that were applied included reinforcing cofactor regeneration, balancing pathway enzyme 
expression, extensive protein engineering of exogenous enzymes, multi-copy genomic 
integration, and optimization of fermentation conditions. Despite the copious attempts, 
the final titers and yields of aromatic compounds remain low.  
The inefficient production is mainly ascribed to two hindrances. First, the 
availability of pathway precursors is constrained by the tight hierarchical regulations 
imposed on yeast central metabolism to avoid unnecessary energy expenditure. For 
example, the first committed step of the shikimate pathway is the condensation of 
phosphoenolpyruvate (PEP) derived from glycolysis and erythrose-4-phosphate (E4P) 
from pentose phosphate pathway (PPP). However, the two starter units, E4P and PEP are 
neither abundant nor present at a balanced ratio in S. cerevisiae. Secondly, the 
biosynthesis of aromatic compounds, especially those plant-sourced flavonoids and 




multiple species including bacteria, plants, mammals, and yeast itself. The stepwise loss 
caused by any impairment in the long metabolic pathways would lead to low titers and 
yields. 
Looking beyond model microbial hosts, many nonconventional microorganisms 
possess industrial favorable traits after long-term natural evolution in special 
environments. Introduction of these unique functions horizontally to model hosts without 
compromising is challenging owing to the complicated network regulations exerted in 
original hosts. S. stipitis is prominent for its excellent xylose-assimilating capacity. Since 
xylose is integrated into the central metabolism exclusively via PPP, S. stipitis has 
evolved highly active PPP, which can provide more abundant E4P precursor than S. 
cerevisiae for the production of aromatic compounds. However, the exploration pace of 
S. stipitis is far behind model hosts due to the lack of synthetic biology elements and 
precise genome editing tools. Recent advances in platform technologies and synthetic 
biology greatly expedited our capabilities of engineering microbial organisms. The next-
generation sequencing technology, RNA-seq, can quantitatively measure individual gene 
expression levels in a cost-effective and timely manner; thus, it would be helpful in the 
determination of differential gene expression under various culture conditions and at 
different cultural time points. Moreover, the construction of stable episomal plasmids was 
achieved through the recent discovery of novel centromeric DNA elements from S. 
stipitis. In addition, the revolutionary gene-editing technology, cluster regularly 
interspaced short palindromic repeats (CRISPR)/Cas9, could be adapted for the precise 





Since the abundance of E4P in S. cerevisiae was identified as rate limiting, the 
highly active PPP in S. stipitis was hypothesized to benefit the production of aromatic 
compounds. Thus, objectives were established as the follows: 
1. Development of genetic manipulation tools (e.g., strong and constitutive 
promoters and terminators) to facilitate metabolic engineering of S. stipitis 
2. Screening and characterization of xylose-specific transporters to relieve carbon 
catabolite repression and achieve concurrent glucose/xylose utilization 
3. Production of shikimate in S. stipitis using single carbon source and 
glucose/xylose mixtures 
4. Construction of yeast consortia for the efficient production of benzylisoquinoline 
alkaloids by leveraging the active upstream module in S. stipitis and the well-
optimized downstream module in S. cerevisiae 
a. Screening and characterization of novel shikimate transporters to achieve 
the metabolite transfer from upstream module to downstream module 
b. Ameliorating the titers of the final product via optimizing each module 
independently and altering the cell ratio 
1.3 Thesis Organization 
Chapter 2 reviews recent advances on the simultaneous mixed-sugar conversion 
in microorganisms. The significance of the synchronous mixed-sugar utilization in the 
industrial economical production of value-added chemicals from lignocellulosic 
hydrolysates was discussed. An array of strategies that were used to improve the 




xylose-utilizing pathways, the identification and engineering of xylose-specific 
transporters, and the establishment of microbial consortia, were covered.  
Chapter 3 is devoted to constituting a nonconventional yeast, S. stipitis, for the 
efficient production of shikimate pathway-derived compounds from glucose. The high-
throughput method, RNA-seq, was first used to identify strong and constitutive promoters 
and terminators from S. stipitis grown in mixed sugars. The strength of newly identified 
promoters and terminators were characterized under various culture conditions. Taking 
advantage of the relatively active pentose phosphate pathway naturally existing in S. 
stipitis, efficient shikimate production (3.11 g/L) was achieved after the strong and 
constitutive promoters and terminators were used to reconstitute the shikimate-
accumulating pathway in S. stipitis.  
Chapter 4 is dedicated to the development of yeast consortia for the de novo 
production of high-value benzylisoquinoline alkaloid precursors. The long norcocalurine 
biosynthesis pathway was distributed to S. stipitis and S. cerevisiae as two independent 
modules. The discovery of a novel xylose-specific transporter enabled glucose/xylose co-
utilization in S. stipitis, which pushed metabolic flux to shikimate pathway and resulted 
in the highest shikimate production (4.5 g/L) in yeasts. Two fungal-sourced quinate 
permeases were identified as functional shikimate transporters to facilitate the uptake of 
the connecting molecule, shikimate, in S. cerevisiae. Through independently engineering 
and tuning initial cell ratios of the two specialists, the yeast consortia resulted in a titer of 





Chapter 5 contains the conclusions and future perspectives of this thesis. 
Promising metabolic engineering strategies that can be used to further ameliorate the 





CHAPTER 2 CURRENT STATUS OF ENHANCING THE CO-UTILIZATION OF 
BIOMASS-DERIVED MIXED SUGARS BY YEASTS 
Published in Frontiers in Microbiology, volume 9, Article 3264. 
Abstract 
Plant biomass is a promising carbon source for producing value-added chemicals, 
including transportation biofuels, polymer precursors, and various additives. Most 
engineered microbial hosts and a select group of wild-type species can metabolize mixed 
sugars including oligosaccharides, hexoses, and pentoses that are hydrolyzed from plant 
biomass. However, most of these microorganisms consume glucose preferentially to non-
glucose sugars through mechanisms generally defined as carbon catabolite repression. 
The current lack of simultaneous mixed-sugar utilization limits achievable titers, yields, 
and productivities. Therefore, the development of microbial platforms capable of 
fermenting mixed sugars simultaneously from biomass hydrolysates is essential for 
economical industry-scale production, particularly for compounds with marginal profits. 
This review aims to summarize recent discoveries and breakthroughs in the engineering 
of yeast cell factories for improved mixed-sugar co-utilization based on various 
metabolic engineering approaches. Emphasis is placed on enhanced xylose utilization, 
discovery of xylose transporters free from glucose repression, native xylose-utilizing 
microbes, and creation of microbial consortia for improving mixed-sugar utilization. 












Legitimate concerns regarding the negative environmental impact and 
unsustainability of the petrochemical industry have resulted in extensive exploration in 
microbial production of fuels and chemicals1. Currently, the majority of industrialized 
biochemical processes utilize crop sugar as substrate, which is non-ideal for a multitude 
of reasons, including minimal reductions in greenhouse gas emissions, food versus fuel 
controversy, and uncompetitive margins compared to petrochemical counterparts2-4. 
Research foci have shifted towards utilizing lignocellulosic feedstock for second-
generation fuel and chemical production because of its abundance, sustainability, and low 
price. Although the prospect of second-generation fuel and chemical production offers 
multiple environmental and socioeconomical advantages, its current economic state 
renders the biorenewables industry incapable of competing with the petrochemical 
industry4. Multiple technical hurdles must be overcome to efficiently convert 
lignocellulosic biomass to biofuels/biochemicals. 
Plant biomass is mainly comprised of cellulose, hemicellulose, and lignin with 
proportions of each component depending on the sources of plant biomass5, 6. After 
pretreatment and saccharification processing, the resulting biomass hydrolysates are 
mixtures of various hexoses and pentoses. Next to glucose, xylose is the second most 




all types of sugars from plant biomass hydrolysates is essential for economic conversion 
of plant biomass to fuels and chemicals9. Most microorganisms, including 
Saccharomyces cerevisiae and Escherichia coli, can efficiently utilize glucose as the 
optimal fermentation substrate, whereas non-glucose sugars such as xylose are utilized at 
much lower efficiencies10.  
Because of carbon catabolite repression, nearly all microorganisms utilize glucose 
preferentially over xylose, resulting in extended fermentation periods and lower 
productivities11. Post-glucose depletion, other nutritional elements gradually become 
limited and certain fermentation end-products and/or side products that inhibit cell 
growth begin to accumulate in the culture media, eventually leading to the slow and 
incomplete fermentation of xylose12, 13. To address this issue, it is imperative to engineer 
microorganisms capable of simultaneous co-sugar utilization. Currently, microbial 
mixed-sugar conversion has been mostly studied in model microbial platforms such as E. 
coli and S. cerevisiae because of their well-understood physiology and genetic 
backgrounds, fast cell growth rates, and readily available genetic manipulation tools. 
Moreover, current commercial production of ethanol from sugarcane or cornstarch 
employs S. cerevisiae, and it was predicted that the integration of existing ethanol plants 
with engineered S. cerevisiae that produce biofuels from non-edible plant biomass can 
reduce the total cost by as much as 20%14, 15.  
This review describes recent advances in microbial conversion of mixed sugars 
from plant biomass, mainly focusing on S. cerevisiae. Various strategies used to 
ameliorate simultaneous mixed-sugar fermentation, including pathway introduction and 




creation of microbial consortia, are discussed in detail. The vast majority of the studies 
discussed in this review analyzed bioethanol production. In these contexts, bioethanol is 
simply used as a reporter molecule for assessing mixed-sugar assimilation competence. In 
alignment with the broader scope laid out by the Department of Energy’s Biomass 
Program16, it is the hope that engineered strains can serve as microbial platforms to 
produce a wide array of biochemicals.  
 
2.2 Natural Xylose Pathways and Challenges in Efficient Xylose Utilization 
Xylose, the second most abundant sugar in plant biomass, is metabolized by 
microorganisms mainly via two distinct routes (Figure 1). In native xylose-utilizing 
bacteria, some fungi, and plants, xylose is converted to D-xylulose by xylose isomerase 
(XI or XylA) in a single step17-22, whereas in most innate xylose-utilizing fungi, a more 
complex alternative route consisting of two redox reactions exists. Xylose is first reduced 
to xylitol by an NADPH-preferred xylose reductase (XR). The resulting xylitol is then 
oxidized to D-xylulose by NAD+-dependent xylose dehydrogenase (XDH)23, 24. 
Subsequently, D-xylulose derived from either pathway is phosphorylated by a 
xylulokinase (XKS) into D-xylulose 5-phosphate (D-X5P), which is then channeled into 
the pentose phosphate pathway (PPP)25-27.  
Despite its broad industrial applications, S. cerevisiae cannot natively utilize the 
xylose hydrolyzed from plant biomass, although gene homologues encoding XR, XDH, 
and XKS required for xylose metabolism are present in its genome27. Overexpression of 
these native genes allowed for minimal cell growth on xylose28. Even after extensive 




not metabolize xylose as efficiently as glucose29. This was mainly attributed to the 
imbalanced xylose-utilizing pathway, where the activities of XR and XDH were much 
lower compared to that of XKS. 
To overcome this limitation, heterologous xylose-utilizing pathways were 
introduced into S. cerevisiae. First, despite its inability to ferment xylose, S. cerevisiae 
can grow on D-xylulose30, indicating that simply introducing a heterologous XI enables 
xylose utilization. Brat et al. introduced a highly active, codon-optimized Clostridium 
phytofermentans XI into an industrial S. cerevisiae strain enabled an aerobic cell growth 
rate of 0.057 h-1 and anaerobic ethanol yield of 0.43 g g-1 when cultured in xylose. 
Subsequently, XIs from a series of species were actively expressed in S. cerevisiae27, 31-34. 
To date, many functionally expressed XIs in S. cerevisiae originated from mammal gut 
microflora, suggesting the evolutionary advantage of xylan-degrading bacteria present in 
mammalian guts. These findings have led to mammalian gut commensals serving as a 
repertoire for isolating novel genes involved in plant biomass degradation at standard 
temperatures34. 
 In parallel to the XI pathway, the XR/XDH pathway has also been extensively 
studied in S. cerevisiae in the past few decades. Multitudinous efforts have been made to 
introduce genes encoding XR and XDH from natural xylose-assimilating species 
including Scheffersomyces stipitis, Neurospora crassa, and Candida tenuis into S. 
cerevisiae, leading to recombinant strains that grew aerobically on xylose media35-39. 
However, xylose utilization was very slow in these recombinant strains and a large 
amount of xylitol accumulated, resulting in a low ethanol yield37-39. Further investigation 




of XR and XDH is severe under oxygen-limited and anaerobic conditions, which results 
in excess formation of NADP+ and a shortage of NAD+. Because it lacks a 
transhydrogenase, S. cerevisiae cannot directly convert NADP+ to NAD+27. This 
imbalance is thought to result in xylitol by-product formation, pulling metabolic flux 
away from ethanol production40. Moreover, accumulation of PPP intermediates during 
xylose fermentation indicated that the capacity of the downstream PPP was constrained 
by PPP enzyme insufficiency37. In the next two sections, strategies that have been 
implemented to improve xylose conversion in S. cerevisiae are discussed in detail.  
 
2.3 Strategies for Improving Xylose-Utilizing Pathway in S. cerevisiae 
To mitigate the cofactor imbalance issue, numerous efforts have focused on either 
isolating novel NADH-preferred XR or switching the cofactor specificities of existing 
XRs41, 42 (Figure 2, strategy I). For example, the cofactor specificity of C. boidinii XR 
was altered through computational design of the cofactor binding pocket, and subsequent 
characterization validated that four mutants completely lost activity when NADPH was 
the only available cofactor, and more than 104-fold changes in substrate specificity from 
NADPH to NADH were observed for the mutants CbXR-K272R, S273E, N274G42. 
Expression of the mutant XRs in S. cerevisiae containing the wild-type XDH resulted in 
increased xylose consumption rates, ethanol titers, and yields along with decreased 
xylitol levels35, 43-45. Analogously, this strategy was applied to modify the specificity of 
XDH to NADP+46, 47. The most successful work in changing the preference of XDH from 






Figure 1. Carbohydrate metabolism in microorganisms.  Red dotted line corresponds to 
inhibition. Abbreviation of metabolites—PEP, phosphoenolpyruvate; G6P, glucose-6-
phosphate; 6-PGL, 6-phosphogluconolactone; 6-PGC, 6-phosphogluconate; D-Ri5P, D-
ribulose-5-phosphate; D-X5P, D-xylulose-5-phosphate; R5P, ribose-5-phosphate; G3P, 
glyceraldehyde-3-phosphate; S7P, sedoheptulose-7-phosphate; F6P, fructose-6-phosphate; 
E4P, erythrose-4-phosphate; L-Ri5P, L-ribulose-5-phosphate. Abbreviation of enzymes—
BGL, β-glucosidase; HXK, hexokinase; PYK, pyruvate kinase; PDC, pyruvate 
decarboxylase; ADH, alcohol dehydrogenase; ZWF, glucose-6-phosphate dehydrogenase; 
6PGL, 6-phosphogluconolactonase; GND, 6-phosphogluconate dehydrogenase; RPI, 
ribose-5-phosphate isomerase; RPE, ribulose-5-phosphate epimerase; TKT, transketolase; 
TAL, transaldolase; XR, xylose reductase; XDH, xylose dehydrogenase; XKS, 
xylulokinase; XI/XylA, xylose isomerase; LAD, L-arabitol 4-dehydrogenase; LXR, L-
xylulose reductase; AraA, L-arabinose isomerase; AraB, L-ribulokinase; AraD, L-
ribulose-5-phosphate 4-epimerase.  
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quadruple (D207A/I208R/F209S/N211R) mutations into S. stipitis XDH47 (Figure 2, 
strategy II). The resulting XDH variants displayed a shifted specificity towards NADP+, 
which was more than 4,500-fold higher than that displayed by the wild-type enzyme in 
vitro. Functional expression of the mutants in S. cerevisiae resulted in a maximal 86% 
decrease in xylitol accumulation coupled with a 41% increase in ethanol production 
compared to the control strain containing wild-type XDH48. 
A viable alternative strategy for enabling cofactor balance in S. cerevisiae 
containing the XR/XDH pathway is to enhance the regeneration of NADPH or NAD+. In 
wild-type yeast, NADPH is mainly regenerated via the oxidative portion of the PPP, in 
which two of the three enzymes involved in converting glucose-6-phosphate (G6P) to D-
ribulose-5-phosphate (D-Ri5P) utilize NADP+ as a cofactor (Figure 1). However, this 
conversion is coupled with CO2 formation, inevitably resulting in significant carbon loss 
and low product yield49. To reduce the heavy reliance on the PPP to regenerate NADPH, 
a yeast GPD1 gene, encoding NADP+-dependent D-glyceraldehyde-3-phosphate 
dehydrogenase (GAPDH) originated from Kluyveromyces lactis, was introduced into S. 
cerevisiae containing the XR/XDH pathway49 (Figure 2, strategy III). Compared to S. 
cerevisiae containing endogenous NAD+-dependent GAPDH, overexpression of K. lactis 
GAPDH converted D-glyceraldehyde-3-phosphate (G3P) to 1, 3-bisphosphoglycerate 
using NADP+ as a cofactor, which is beneficial for both regenerating NADPH and 
reducing the accumulation of excessive NADH produced by endogenous GAPDH. When 
the ZWF1 gene encoding glucose-6-phosphate dehydrogenase was simultaneously 
deleted, the K. lactis GAPDH became the major engine replenishing NADPH in 




xylose compared to those in the control strain. The same strategy was applied to improve 
NAD+ availability by heterologously expressing Lactococcus lactis NADH oxidase in S. 
cerevisiae containing the XR/XDH pathway, which mediated the conversion of NADH 
and oxygen to NAD+ and water50-53 (Figure 2, strategy IV). Introduction of the water-
forming NADH oxidase mitigated this cofactor imbalance by converting excess 
intracellular NADH to NAD+50, 51. During xylose fermentation, the recombinant strain 
overexpressing NADH oxidase from L. lactis demonstrated a 69.63% decrease in xylitol 
accumulation, a 53.85% reduction in glycerol production, and a 39.33% increase in 
ethanol yield52. 
In addition to NADH oxidase, other NAD+-regenerating pathways were explored. 
For example, Wei et al. confirmed that in yeast, acetate can be converted to ethanol 
catalyzed by the endogenous acetyl-CoA synthetase and alcohol dehydrogenase (ADH) 
in conjunction with the heterologous acetylating acetaldehyde dehydrogenase (AADH) 
using NADH as a cofactor54 (Figure 2, strategy V). A group of AADH homologues 
were tested, including bifunctional proteins isolated from E. coli, Piromyces Sp. E2, and 
Clostridium beijerinckii (catalyzing the conversion of acetyl-CoA to acetaldehyde 
followed by subsequent conversion to ethanol), and the proteins involved in ethanolamine 
or 4-hydroxy-2-ketovalerate catabolism from E. coli. Introduction of these homologues 
into S. cerevisiae harboring the XR/XDH pathway enabled simultaneous acetate and 
xylose consumption under anaerobic conditions. The highest improvement was achieved 
by overexpressing the bifunctional E. coli AdhE, which led to 17% and 21% increases in 
ethanol yield and productivity, respectively. This improvement was attributed to the 




byproducts. The superiority of this system is conferred by co-utilization of xylose and 
acetate, the latter of which is a ubiquitous inhibitor present in plant biomass hydrolysates 
and serves as a redox sink for consuming surplus NADH.  
Although D-xylulose, the product of XR/XDH-catalyzed conversion, can be 
metabolized by S. cerevisiae, it is consumed much more slowly than glucose55, 56. 
Numerous independent studies indicated that merely introducing XI or XR/XDH resulted 
in substantial accumulation of D-xylulose in S. cerevisiae31, 57, 58. These observations 
suggested insufficient activity of endogenous XKS. To overcome this inadequacy, genes 
encoding XKS from multiple sources were expressed in recombinant S. cerevisiae 
harboring either the XI or XR/XDH pathway31, 59-62. Notably, excessive XKS activity 
may increase metabolic burden and cause excessive ATP consumption, impairing cell 
growth and diminishing ethanol yield61, 63. In this regard, fine-tuned XKS activity is 
essential for optimizing xylose fermentation in recombinant S. cerevisiae strains. As a 
result, moderate XKS activity coupled with the high activity of XR and XDH is optimal 
for xylose conversion64, 65. 
 
2.4 Strategies for Improving PPP in S. cerevisiae for Efficient Xylose Assimilation  
The PPP is the entry point for integrating D-xylulose into central carbon 
metabolism. Therefore, the activity of PPP enzymes is crucial for efficient pentose 
assimilation27. Because of the low capacity of the non-oxidative portion of the PPP66, S. 
cerevisiae containing a xylose-assimilating pathway accumulated PPP intermediates, 






Figure 2. Implementation of metabolic engineering strategies in S. cerevisiae to enhance 
xylose utilization via ameliorating cofactor imbalance, including (I) discovery of NADH-
preferred XR variants; (II) discovery of NADP+-preferred XDH variants; (III) enhancing 
of NADPH regeneration through overexpressing NADP+-dependent GAPDH; (IV) 
enhancing of NAD+ regeneration through overexpressing noxE; (IV) improving NAD+ 
regeneration through the integration of acetate-consuming pathway. Abbreviation of 
metabolites—1,3-BPG, 1,3-bisphosphoglycerate; 6-PGL, 6-phosphogluconolactone; 
G6P, glucose-6-phosphate; G3P, glyceraldehyde-3-phosphate. Abbreviation of 
enzymes—XR, xylose reductase; XDH, xylose dehydrogenase; ZWF, glucose-6-
phosphate dehydrogenase; GAPDH, glyceraldehyde-3-phosphate dehydrogenase; noxE, 
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sedoheptulose-7-phosphate (S7P)37, 55, 67 (Figure 1). In addition to strategies of elevating 
the expression level of the endogenous transketolase (TKT1) and transaldolase (TAL1), 
researchers have attempted to overexpress the homologues of the key enzymes involved 
in the PPP to improve pathway flux in xylose-fermenting yeast. Some previous studies 
reported that overexpression of S. stipitis TKT1 in S. cerevisiae containing the XR/XDH 
pathway did not affect xylose utilization and in some cases caused significant metabolic 
burden and drastically extended the cell-doubling time on xylose68, 69. In contrast, other 
studies indicated that overexpression of either the endogenous or heterologous TAL1 
from S. stipitis in xylose-utilizing S. cerevisiae enhanced cell growth on xylose69, 70. 
Specifically, S. cerevisiae transformed with XR, XDH, XKS, and TAL1 isolated from S. 
stipitis grew twice as fast on xylose and produced 70% more ethanol compared to the 
control strain overexpressing only XR/XDH/XKS70. Moreover, two parallel studies 
reported the overexpression of genes encoding the entire non-oxidative PPP, including 
ribose-5-phosphate isomerase (RPI), ribulose-5-phosphate epimerase (RPE), TKT1, and 
TAL1, in the recombinant xylose-fermenting S. cerevisiae, along with deletion of the 
gene encoding aldose reductase (GRE3) that mediates unwanted production of xylitol71, 
72. The resulting strains demonstrated improved cell growth rate (0.22 h-1 and 0.17 h-1) 
and enhanced ethanol production (0.43 g g-1 and 0.29 g g-1) on xylose (Figure 1).  
 
2.5 Exploration of Novel Xylose Transporters 
Great efforts had been devoted to improving the metabolic flux of intracellular 
pentose utilization, but sugar transport was later recognized as an outstanding limiting 




cerevisiae lacks xylose-specific transporters, the native hexose transporters, including 
HXT1, HXT2, HXT4, HXT5, HXT7, and GAL2, are responsible for mediating xylose 
transport75-78. However, the hexose transporters possess 10–100-fold higher affinity for 
glucose than for other sugars, resulting in a glucose preference over other sugars, 
extending mixed-sugar fermentations process8, 73, 79. Therefore, mining and/or 
engineering xylose-specific transporters insensitive to glucose are very important for 
economic conversion of mixed sugars present in biomass hydrolysates. EBY.VW4000, 
deprived of 18 hexose transporters and three maltose transporters that transport hexoses, 
has been used as a platform for characterizing xylose transporters80. 
The first non-native xylose transporters successfully expressed in S. cerevisiae 
were GXF1 and GXS1 from Candida intermedia81. After then, other putative xylose 
transporters from diverse organisms, including plants, algae, fungi, and bacteria, were 
expressed in S. cerevisiae to improve xylose uptake76, 78, 82-86. Because of potential 
improper localization or misfolding, many of these proteins did not enable xylose uptake 
in S. cerevisiae despite their high homology to known xylose transporters. For example, 
using the sequence of GXS1 as a query, a study aimed to discover novel xylose 
transporters from native xylose-assimilating yeasts, S. stipitis and N. crassa86. Among a 
total of 18 putative xylose transporters, An25 and Xyp29 were identified as xylose-
specific. Their expression on the membranes of S. cerevisiae was confirmed and xylose 
was accumulated intracellularly because of the scarcity of an efficient xylose-utilizing 
pathway in the engineered S. cerevisiae strain. In a subsequent study, a collection of 36 
putative sugar transporters was thoroughly characterized for their substrate acceptance 




based assays demonstrated that three transporters, XUT1 and XUT3 from S. stipitis and 
XylHP from Debaryomyces hansenii, transported xylose efficiently and demonstrated 
higher xylose preference than other transporters in the hexose transporter-null strain 
background.  
Unfortunately, regardless of the performance of these transporters in xylose media, 
all of these transporters were subject to glucose repression in mixed-sugar fermentation 
or suffered from low xylose-uptake efficiency76, 82-86. In this regard, to resolve the CCR 
problem and promote efficient biochemical production, numerous independent studies 
were conducted to reshape the existing transporters via rational design or evolutionary 
engineering74, 87-93. Presumably, glucose repression can be exerted outside of the xylose-
binding pocket. The very first transporter engineering work was performed by Young et 
al.87. Starting with C. intermedia GXS1 and S. stipitis XUT3, five mutants with improved 
xylose uptake activities were generated by employing a directed evolution method. 
Kinetic studies indicated that some mutated transporters obtained increased affinity to 
xylose (lower Km) and higher uptake rates (higher Vmax), with the best mutant amplifying 
the yeast cell growth rate on xylose by 1.7-fold compared to its corresponding wild-type. 
Relieved CCR and enhanced sugar assimilation were observed in mixed-sugar 
fermentation. The phenylalanine residue at position 40 of GXS1 and glutamine residue at 
position 538 of XUT3 were found to largely contribute to influencing the transportation 
characteristics.  
Inspired by the observation that sugar transporter preference does not require a 
trade-off for its efficiency, multiple primary hexose transporters were engineered to be 




protein motif G-G/F-XXX-G surrounding the previously reported GXS1-F40 residue was 
recognized to dominate the transporters displaying high efficiency in xylose transport74. 
Through a series of saturation mutagenesis followed by rational mutagenesis, four 
xylose-exclusive transporters variants, CiGXS1F38I39M40, SsRGT2F38, SsRGT2M40, and 
ScHXT7I39M40M340, were obtained. The four mutants conferred robust cell growth on 
xylose in EBY.VW4000, although they were still inhibited by glucose, presumably via 
allosteric binding. Nearly concurrently, Farwick at al. built an easy yet precise xylose-
specific transporter screening system by disrupting the first step of the glycolytic 
pathway88. Through growth-based screening under mixed-sugar conditions, a 
combinatorial strategy of evolutionary engineering and site-specific mutagenesis led to 
the discovery of several mutations that contributed to mitigating glucose inhibition. 
Specifically, simply altering threonine 219/213 and asparagine 376/370 of S. cerevisiae 
GAL2/HXT7 resulted in mutant transporters possessing extraordinary properties, 
including attenuated or completely abolished glucose affinity, enhanced xylose affinity, 
and decreased glucose competitive repression. This is the first study in which primary 
hexose transporters were engineered to be both glucose-insensitive and xylose-specific. 
Subsequently, various independent studies reported that hexose transporters such as S. 
cerevisiae HXT3689, HXT1190, HXT791, C. intermedia GXS193, and pentose transporter 
(e.g., N. crassa An2592) were engineered to relieve glucose inhibition and improve xylose 
uptake. These transporter-engineering studies suggested that direct evolution and 
combinatorial mutagenesis are potent protein engineering tools for expanding the 




To facilitate uptake and in situ intracellular conversion of xylose before diversion, 
a very intriguing study was recently conducted to construct an artificial enzyme-
transporter complex in S. cerevisiae94. After a series of optimizations, a scaffold-based 
complex successfully recruited the heterologously expressed C. phytofermentans XI to 
the endogenous GAL2 localized on the membrane, which did not negatively affect the 
activities of both proteins. Because of the ameliorated substrate transportation and 
channeling, the xylose consumption rate and ethanol titer were remarkably increased with 
substantially diminished accumulation of the undesired byproduct, xylitol.  
 
2.6 Native Xylose-Utilizing Yeasts 
Most recent studies used EBY.VW4000 or its derivatives as the transporter-
screening platform. However, this strain grows slowly because of its defects in meiosis 
and centromere segregation caused by large chromosome translocations95. In this regard, 
EBY.VW4000 is a good strain for transporter screening but not for industrial mixed-
sugar conversion. Moreover, as described previously, xylose fermentation in engineered 
S. cerevisiae is accompanied by co-factor imbalance and subsequently low metabolic flux. 
Thus, a highly promising alternative to engineering industrial friendly model hosts to 
efficiently utilize mixed sugars is ameliorating innate xylose-utilizing microorganisms96. 
The CUG clade is a group of nonconventional yeasts that translate the CUG codon to 
serine rather than leucine97. Unlike S. cerevisiae, most CUG clade yeasts can uptake and 
metabolize xylose much more efficiently. Specifically, S. stipitis and S. passalidarum are 
particularly intriguing because of their ability to convert xylose to ethanol at high yields 




converted xylose to ethanol with a yield of 0.43 g ethanol g-1 xylose and exhibited 
minimal glucose repression in a mixed-sugar assay99. However, because of the dominant 
non-homologous end joining mechanism for repairing DNA double strand breaks and a 
lack of genetic manipulation tools, the exploration pace of CUG clade yeasts has been 
limited, preventing their applications in industrial biofuel/biochemical production. Recent 
advances in synthetic biology have greatly expedited progress in engineering non-
conventional yeasts100. For example, a series of genetic manipulation tools for S. stipitis 
were reported, including strong and constitutive promoters and terminators101, a stable 
episomal expression plasmid created by successful isolation of native centromeres102, 103, 
and CRISPR-enabled precise genome editing tools104. Through utilization of these tools, 
studies have demonstrated the possibility of engineering S. stipitis to an efficient platform 
in the near future for producing a specific group of biochemicals (i.e., shikimate pathway 
derivatives101, 105) or biofuels directly from biomass hydrolysates containing hexoses and 
pentoses. 
In addition to the CUG clade yeasts, oleaginous yeasts, such as Yarrowia 
lipolytica and Psedozyma hubeiensis, also exhibit native mixed-sugar consumption 
capabilities. Employing comprehensive metabolic and transcriptomic analysis strategies, 
a recent study unraveled the genes responsible for xylose and cellobiose uptake and 
metabolism in Y. lipolytica106. Simultaneous mixed-sugar utilization was achieved, which 
was attributed to mild glucose repression in conjunction with strong carbon catabolite 
activation for growth on xylose and cellobiose. In another study, through exhaustive 
screening of 1,189 yeast isolates, Tanimura et al. demonstrated P. hubeiensis IPM1-10 




accumulated high amounts of lipid107. These findings suggest the importance of 
broadening the current collection of microbial species for efficient fermentation of 
multiple sugars in biomass hydrolysates. 
 
2.7 Applying Consortia in Mixed-Sugar Conversion 
Engineering microbial communities represents a new frontier of synthetic biology 
and has garnered increasing attention in recent years108. Microbial co-culture systems can 
perform complex tasks via labor division. Compared to monocultures, multi-step 
metabolic pathways can be compartmentalized to different hosts in the consortium, which 
not only alleviates the heavy metabolic burden on a single species, but even more 
importantly provides the option of optimizing segmented pathways separately to avoid 
compromise and minimizing the accumulation of metabolic intermediates as 
byproducts109. In nature, communities respond more robustly to environmental 
fluctuations such as nutrient limitation, and this feature may be particularly useful for the 
fermentation of biomass hydrolysates when sugar choices and concentrations are 
shifting108. In this section, the applications of both natural and synthetic consortia for 
enhancing mixed-sugar consumption and improving biochemical production are 
discussed. Although this review mainly focuses on yeast engineering, a few interesting 
bacterium consortium examples are included below.   
Microbial consortia are ubiquitous in nature, and synergistic interactions among 
community species are established after long-term evolution in specific environments108. 
Applying natural consortia in mixed-sugar utilization is beneficially associated with non-




consortia enriched from geothermal spring were evolved to produce hydrogen from 
glucose/xylose mixtures and hydrolysates of oil palm trunk with yields of 375 and 301 
mL H2 g-1 sugar consumed, respectively111. The dominant species in the consortia were 
Thermoanaerobacterium sp., Thermoanaerobacter sp., Caloramater sp., and 
Anoxybacillus sp. In addition to the major product hydrogen, multiple byproducts were 
detected, including butyric acid, acetic acid, lactic acid, and butanol. Although natural 
consortia are durable under varying culture conditions because of their high self-
tunability and have been applied to complex tasks such as wastewater treatment and 
lignocellulosic biomass deconstruction, their uncontrollability limits their wide 
application in producing specific biochemicals at high titers110. The physiology and 
genetic background of members of natural consortia are not well-characterized, further 
complicating determination of the interaction mechanisms in the microbial community. 
To address this issue, significant progress has been made in the design and 
characterization of synthetic microbial consortia because of their relatively simple 
interplays110. The simplest design is to build a synthetic community with strains from the 
same species, which avoids growth incompatibility issues, including temperature, pH, 
nutrition requirement, and cell growth rate. Eiteman at al. developed an E. coli/E. coli 
community for simultaneous conversion of glucose and xylose to a mixture of valuable 
products, including formate, lactate, ethanol, and succinate112. One of the two community 
members was engineered to be glucose-exclusive with its native XI deleted, while the 
other was xylose-selective with three genes involved in glucose uptake and 
phosphorylation disrupted. Rather than adversely competing with each other, the two E. 




consumption rate than the monocultures. The distinguishing hallmark of the consortium 
strategy is the robustness and flexibility provided by the system. Fed-batch fermentation 
indicated that this consortium adjusted the distribution of each strain based on 
fluctuations in the feed sugar concentration. For example, when xylose concentration is 
higher than glucose in the feed stream, the xylose-consuming strain would be dominant, 
and vice versa. Subsequently, the same group further extended the consortium approach 
to the simultaneous consumption of glucose, xylose, and arabinose along with acetate, 
which is a growth inhibitor typically present in lignocellulosic hydrolysates113. Four E. 
coli strains engineered to be single substrate-selective were co-inoculated, and 
synchronous utilization of four substrates was achieved, although the xylose and 
arabinose consumption rates were decreased by 14% and 11%, respectively, compared to 
those in the wild-type strain.  
Employing the analogous rationale to explore the synchronous conversion of 
glucose/xylose/arabinose mixtures, a consortium system consisting of three S. cerevisiae 
specialists was established very recently114. Both xylose- and arabinose-exclusive 
specialists were constructed via disrupting hexose phosphorylation followed with 
adaptive evolution. Despite the rapid consumption of glucose and arabinose by three-
strain co-culture, xylose utilization was severely impaired possibly due to (by-)product 
inhibition. Only after substantial anaerobic laboratory evolution xylose utilization was 
significantly improved, eventually leading to the simultaneous depletion of all three 
sugars. Moreover, the evolved three-strain consortium was more stable and robust than a 
pentose-fermenting yeast monoculture during long-term cultivation. Very recently, a 




cervisiae co-cultures. This model, which incorporated pure culture models, product 
inhibition effects, initial substrate concentrations, and inoculum sizes, accurately 
predicted independent experimental results115. Implementation of the model prediction 
enabled co-fermentation of 60 g L-1 cellobiose and 20 g L-1 xylose in a S. cerevisiae/S. 
cerevisiae co-culture 
A stable E. coli/E. coli integrated system that produced high-value compounds 
from glucose/xylose mixtures was constructed and optimized109 (Figure 3a). To 
overcome the lingering high leakage of pathway intermediates and non-efficient sugar 
utilization, the multi-step cis, cis-muconic acid (MA) synthesis pathway was split into 
two independent E. coli strains. One strain preferred xylose and contained the shikimate 
pathway, which catalyzed the conversion of xylose to the intermediate dehydroshikimate 
(DHS). The other strain preferred glucose and harbored the exogenous DHS-to-MA 
synthesis pathway together with a DHS transporter. As a result, glucose/xylose co-
consumption was achieved, eliminating carbon source competition in the community. 
Additionally, the microbial community improved the MA titer to 4.7 g L-1 with a yield as 
high as 0.35 g g-1 sugar mixture. Because of the tunability and dynamic growth balance 
exhibited by the two constituent members, the community was more robust for handling 
varying mixed-sugar concentrations. Finally, the co-culture concept was extended to 
produce 4-hydroxybenzoic acid (4HB) using the DHS-producing strain and a new strain 
that converted DHS to 4HB. Through simple independent engineering of the new strain, a 
final titer of 2.3 g L-1 4HB was obtained, and the obtained yield of 0.11 g g-1 was 





Compared to single-species consortia, manipulating communities comprising multi-
species is more complicated. This is attributed to the community instability caused by 
different growth rates and difficulty in building cell-cell communication across species. 
Solving these instability issues would be advantageous, since multi-species consortia 
possess unique advantages. A wider array of mixed species offer higher flexibility and 
capability to achieve more complex tasks. Additionally, a better understanding of multi-
species consortia is beneficial for future studies to break the confines of model 
microorganisms and exploit non-model hosts, particularly those with desirable 
phenotypes but are recalcitrant to genetic modifications. Numerous studies have focused 
on developing microbial consortia of S. cerevisiae and a native pentose-fermenting yeast 
for efficient hexose/pentose co-utilization. For example, under oxygen-limited and 
continuous culture conditions, the co-cultured S. stipitis and respiratory-deficient S. 
cerevisiae system converted 35.0 g L-1 glucose and 10.4 g L-1 xylose and displayed 
enhanced ethanol yield at 0.42 g g-1 sugars119. Such a co-cultured yeast system was further 
optimized via adjusting the agitation rate, temperature, and continuous dilution rate120-122. 
To identify the key determinants of the performance of this S. cerevisiae/S. stipitis co-
culture system, a dynamic metabolic flux balance model was constructed123 and an 11% 
improvement in ethanol productivity was observed by adjusting the aeration level and 
inoculation concentrations predicted by the model. Slow xylose uptake and conversion 
were determined as the key factors restraining ethanol production by this S. cerevisiae/S. 







Figure 3. Exemplary engineered microbial consortia. (a) An E. coli/E. coli consortium 
for improved production of MA and 4HB from a glucose/xylose mixture169; (b) A T. 
reesei/E. coli consortium for direct conversion of biomass hydrolysates to isobutanol116; 
(c) A T. reesei/S. cerevisiae/S. stipitis biofilm membrane reactor integrating aerobic 
cellulolytic enzyme production and anaerobic ethanol accumulation117. The images were 
prepared according to the previous individual studies. Abbreviation of metabolites— 
PEP, phosphoenolpyruvate; E4P, erythrose-4-phosphate; DHS, dehydroshikimate; MA, 
cis, cis-muconic acid; 4-HB, 4-hydroxybenzoic acid; CBHI, cellobiohydrolase I; CBHII, 
cellobiohydrolase II; EG, endoglucanase; BGL, β-glucosidase.  
 
 
A unique synthetic fungal-bacterial mixed population was developed for 
isobutanol production directly from plant biomass116 (Figure 3b). Isobutanol is a highly 
sought-after next-generation biofuel with advantageous properties as a gasoline 




compared to ethanol124. This consortium system integrated cellulase secretion, sugar 
saccharification, and fermentation via combining T. reesei, an active cellulase-producing 
host, and E. coli that was engineered to convert sugars to isobutanol. The dedicated 
design maintained a very low glucose concentration in the medium. A comprehensive 
ordinary differential equation model established including 50 parameters revealed that T. 
reesei and E. coli coexisted stably despite the isobutanol toxicity effect. When using 
pretreated corn stover as substrate, various sugars in the hydrolysates were co-consumed 
and isobutanol production titer and yield reached 1.88 g L-1 and 62%, respectively. 
Dividing the entire isobutanol process into T. reesei and E. coli provided an optimal 
environment for functional expression of both the cellulase-producing pathway and 
sugar-conversion pathway. Moreover, the modular design could facilitate rapid adaption 
of the consortium system to produce a portfolio of advanced chemicals from plant 
biomass.  
A more complicated, multi-species biofilm membrane (MBM) reactor was used to 
produce ethanol from undetoxified pretreated wheat straw117 (Figure 3c). The 
meticulously designed MBM system maintained an optimal environment for each of the 
three specialists, namely T. reesei, S. cerevisiae, and S. stipitis, for cellulase production, 
glucose-to-ethanol conversion, and xylose-to-ethanol conversion, respectively. In MBM 
fermentation, a maximum of 9.8 g L-1 ethanol with a yield of 69% was obtained, which 
was substantially higher than the ethanol titer (4.6 g L-1) and yield (41%) obtained by co-
culture of the engineered S. cerevisiae and S. stipitis using the same substrate. Despite the 




residual cellobiose in plant biomass hydrolysates must be resolved before this system can 
serve as an efficient platform for economic biochemical production. 
 
2.8 Conclusions and Future Perspectives 
Grave concerns regarding the future availability of fossil fuels, coupled with the 
negative environmental ramifications of the globe’s current carbon footprint, is driving 
the initiative towards “green” fuels and chemicals. Unfortunately, first generation 
biorenewable products made from food crops led to the concerns to food security and the 
competition with the land used for food crops. Instead, utilization of lignocellulosic 
biomass as the second-generation feedstock for fuel and chemical production has 
numerous potential environmental and societal advantages compared to its petroleum and 
sugar feedstock counterparts. Since 2008, global efforts from major chemical/fuel 
companies (e.g., POET, Raizen, etc.) have turned dozens of commercial or semi-
commercial scale cellulosic ethanol plants into operation. A typical cellulosic ethanol 
plant has a production capacity of dozens of million gallons per year, which is still far 
away from the total consumption rate of petroleum. As a reference, the U.S. petroleum 
consumption was estimated to be an average of about 840 million gallons per day in 
2017. Despite the price fluctuation of crude oil in the past decade (in a range of $30 to 
$110 per barrel), bioethanol production needs to be near $70 per barrel in order to be 
economically competitive, which makes the co-utilization of all the sugars present in 
biomass hydrolysates very important. Therefore, future efforts should focus on 





Previous studies of mixed-sugar fermentation on S. cerevisiae were mostly 
isolated and had limited crossovers, which have proven problematic since intracellular 
metabolic flux and sugar uptake can both restrict maximal production rates. Thus, future 
efforts should shift towards developing robust strains for industrial biomass hydrolysate 
conversion via applying global cellular engineering strategies. Instead of focusing solely 
on increasing pathway flux and sugar transportation, engineering strategies should go 
beyond this superficial level, aiming to expand our current understanding to unveil the 
native regulatory mechanisms underlying non-glucose utilization in S. cerevisiae. For 
example, evolutionary engineering followed by genome re-sequencing of evolved S. 
cerevisiae strains with beneficial phenotypes elucidated that reduced glucose 
phosphorylation rates enabled simultaneous glucose/xylose utilization125, 126. 
Comparative transcriptomic analysis on the natural S. cerevisiae YB-2625 strain isolated 
from bagasse and the model yeast strain S288C also revealed that multiple factors 
contributed to the exceptional xylose-consuming capability127. Some factors were rather 
obvious, such as down-regulation of hexokinase and genes involved in glucose-
repression related transcription factors. However, other factors were quite intriguing. 
These included up-regulation of genes encoding antioxidant enzymes, a less than obvious 
link to xylose uptake and utilization. Such interventions would not have been easily 
discovered without a global analysis approach. 
Expanding the current collection of microbial factories for the highly sought-after 
cosugar-utilizing phenotype presents a new frontier in the biochemical industry. A high-
throughput screening method of desired characteristics must first be developed to 




prevalent microbiome and metagenomic analyses will revolutionize our ability to identify 
new microbial species at an unprecedented rate128. Newly identified nonconventional 
microbes will create an urgent demand for corresponding genetic manipulation tools, 
specifically platform technologies that can be easily transferred from one species to 
another. Extension of current CRISPR-Cas technology to non-conventional yeasts will 
enable precise genome modification, convenient pathway engineering, and wide genetic 
interaction analysis128. Other platform technologies, such as CRISPR-mediated base-
editing platforms and RNA-seq, are beneficial for expeditious mapping superior 
phenotype to genotype. 
After extensive review of the current literatures, efficient engineering of 
heterogeneous consortia arises as a highly promising strategy in achieving the ultimate 
goal of converting lignocellulosic biomass to biofuels/biochemicals in an economically 
competitive manner. However, several challenges must be overcome before such systems 
can be adapted to commercial production. First, unlike their natural counterparts, 
synthetic communities cannot retain long-term homeostasis, particularly under industrial 
harsh conditions containing inhibitors and toxins108. Thus, combinatorial approaches, 
such as evolutionary engineering combined with further development of bioreactors for 
long-term culturing and monitoring, should be implemented to increase the robustness 
and fine tune the efficiency of consortia129. Additionally, computational tools should be 
harnessed to develop dynamic models to facilitate discovery and understanding variables 
most crucial to system performance115, 130. These models can also provide rational 




In addition to efficient utilization of all carbohydrates in the biomass 
hydrolysates, engineering efforts should also be directed towards in situ fixation of the 
CO2 produced through numerous decarboxylation reactions182. For example, various CO2 
conservative pathways, such as the non-oxidative glycolysis131, the methanol 
condensation pathway132, reductive PPPs (rPPPs)133, 134, and the 3-hydroxypropionate 
pathway135, have been successfully introduced into either E. coli or S. cerevisiae. To 
alleviate CO2 emissions and remove the surplus NADH generated via the XR/XDH 
pathway, synthetic rPPPs were incorporated into xylose-utilizing S. cerevisiae strains, 
resulting in higher ethanol yields and lower byproducts yields (e.g., glycereol and xylitol) 
during xylose-fermentation133, 136. Implementing CO2 conservative pathways, in 
conjunction with optimization of microbial consortia via global engineering strategies, 
has the potential to expedite the development of an economic, sustainable, and 
environmentally-friendly lignocellulosic-based biochemical industry.   
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CHAPTER 3 INNOVATING A NONCONVENTIONAL YEAST PLATFORM 
FOR PRODUCING SHIKIMATE AS THE BUILDING BLOCK OF HIGH-
VALUE AROMATICS 
Published in ACS Synthetic Biology, volume 6: p29-38. 
Abstract  
The shikimate pathway serves an essential role in many organisms.  Not only are 
the three aromatic amino acids synthesized through this pathway, but many secondary 
metabolites also derive from it.  Decades of effort have been invested into engineering 
Saccharomyces cerevisiae to produce shikimate and its derivatives.  In addition to the 
ability to express cytochrome P450, S. cerevisiae is generally recognized as safe for 
producing compounds with nutraceutical and pharmaceutical applications.  However, the 
intrinsically complicated regulations involved in central metabolism and the low 
precursor availability in S. cerevisiae has limited production levels.  Here we report the 
development of a new platform based on Scheffersomyces stipitis, whose superior xylose 
utilization efficiency makes it particularly suited to produce the shikimate group of 
compounds.  Shikimate was produced at 3.11 g/L, representing the highest level among 
shikimate pathway products in yeasts.  Our work represents a new exploration towards 
expanding the current collection of microbial factories. 
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Recent advances in metabolic engineering have revolutionized the ability to 
engineer platform organisms to produce a wide variety of value-added compounds with 
broad applications as fuel, chemicals, and pharmaceuticals1.  Among these microbial 
factories, a number of yeast species, in particular Saccharomyces cerevisiae, have been 
widely successful due to their relatively well-characterized physiology and genetics, fast 
cell-growth rates, and the availability of tools for genetic manipulation.  In terms of 
industry-scale fermentation, compared to bacterium platforms, yeast-based production 
brings additional economic advantages, for instance, a greater ease for maintaining 
phage-free cultivation conditions.  In addition, the downstream biomass byproducts (i.e. 
yeast extract) can often be sold separately as animal feed, therefore further increasing the 
overall profit2, 3.  More importantly, yeasts have the unique capabilities of expressing 
membrane-associated cytochrome P450 enzymes, which enables the synthesis of 
complex molecules such as plant-derived natural products that often possess important 
medicinal properties4. 
Shikimate is an essential precursor for many alkaloid and flavonoid types of 
secondary metabolites.  These biologically active compounds are derived via 
decarboxylation or deamination of aromatic amino acids, the synthesis of which 
originates from the shikimate pathway (Figure 1a).  In addition to its ability to express 
P450 enzymes, S. cerevisiae is generally recognized as safe (GRAS) for producing 
compounds for use as nutraceutical and pharmaceutical ingredients5.  Breakthroughs 
include the production of the antioxidant naringenin (113 mg/L)6, and the recent 




hydrocodone)7.  Although the low titers are caused mainly by stepwise loss at incomplete 
conversion steps in the pathways, the relatively low precursor availability provided by the 
shikimate pathway was noticed in S. cerevisiae as opposed to bacterial production hosts8, 
9.  To the best of our knowledge, none of the shikimate pathway-derived compounds 
developed in yeast batch fermentation have yielded titers even close to 1 g/L (Table S1), 
the minimal level required for progression from lab-scale proof-of-concept research to 
small-scale process development, with the ultimate goal of attracting future commercial 
interest. 
Shikimate itself is also a versatile enantiomeric precursor for the chemical 
synthesis of many biologically active compounds because it has a highly functionalized 
six-carbon ring with three chiral carbons (Figure 1b)10.  Oseltamivir phosphate, more 
commonly known as Tamiflu®, is used for the treatment of seasonal influenza, and is 
synthesized from shikimate via ten chemical conversions11.  The current processes used 
to synthesize shikimate, which was commercialized by Roche, include the extraction 
from Chinese star anise, the fruit of the Illicium verum plant.  It is estimated that 30 
billion doses of Tamiflu®, equivalent to 3.9 million kg of shikimate, would be required to 
treat a severe influenza outbreak12.  However, approximately 30 kg of fruit are needed to 
produce merely 1 kg of shikimate13, and it takes 6 years of growth before Illicium verum 
bears fruit.  Open-field crop growth and the resulting price is also inevitably susceptible 
to environmental factors, which is often associated with variability in product yield and 
composition14.   
Roche also ferments genetically engineered Escherichia coli to produce shikimate 




supply in a more timely manner and confined space.  After a decade of research 
development, the production in E. coli has been improved to 87 g/L8, in contrast to the 
low titers of shikimate derivatives produced using yeast platforms (Table S1).  
Nonetheless, considering the ultimate goal of reconstituting complex pathways to 
synthesize shikimate-derived natural products with nutraceutical and pharmaceutical 
applications, exploring the potential of shikimate production in yeasts is still of 
importance.  Here, we report the development of a nonconventional yeast species, 
Scheffersomyces stipitis, well known for its superior native xylose utilization capability15, 
to synthesize shikimate at a level of 3 g/L.  This represents the highest titer achieved 
among all of the shikimate pathway-derived products that have so far been attempted in 
yeast.  Attempts at downstream processing also proved that shikimate could be easily 
recovered from yeast fermentation broth for further derivatization.  
  
3.2 Materials and Methods 
3.2.1 S. stipitis cultivation and RNA isolation 
The S. stipitis FPL-UC7 strain31 (ura3-3, NRRL Y-21448, a gift from Dr. Thomas 
W. Jeffries at University of Wisconsin-Madison) was initially grown on YPAD plate for 
3-4 days.  A single colony was inoculated into a 500 mL baffled flask (VWR, Chicago, 
IL) containing 50 mL YPAD liquid medium and cultured at 30°C with 250 rpm orbital 
shaking for 4 days.  The resulting culture was transferred to 1 L anaerobic bottles 
(Chemglass Life Sciences, Vineland, NJ) containing 600 mL of either YPA plus 3.5% 
glucose, YPA plus 3.5% glucose and 1.5% xylose, or YPA plus 1.5% xylose with an 




approximate abundance of the two sugars in commonly studied biomass45, 46.  Cells were 
grown at 30°C with 200 rpm orbital shaking and the anaerobic bottles were covered with 
double layers of foil to maintain oxygen-limited condition.  Cell pellets with a total 
OD600~50 were harvested at three time points (15 hr, 48 hr, and 72 hr) and stored at -
80°C.  Total RNA was isolated using RNeasy mini kit (Qiagen, Valencia, CA) followed 
by removal of genomic DNA contamination with Turbo DNA-free kit (Life 
Technologies, Carlsbad, CA) according to the manufacturer’s instructions.  
3.2.2 Plasmid construction and transformation 
A single colony of S. stipitis FPL-UC7 was initially grown in 3 mL YPAD liquid 
media with 250 rpm orbital shaking until OD600 reached ~3.0.  Genomic DNA was 
extracted from S. stipitis FPL-UC7 using a Wizard genomic DNA purification kit 
(Promega, Madison, WI).  Promoters of various lengths were amplified from S. stipitis 
FPL-UC7 genomic DNA, co-transformed with the amplified egfp and TEF1t fragments, 
and assembled into the plasmid pMG1 linearized by XhoI and ClaI (Thermo Scientific, 
Waltham, MA) (Figure S3).  The assembly was performed in S. cerevisiae YSG50 using 
the DNA assembler approach previously described, in which 40 bp homologous regions 
were designed between adjacent fragments47, 48.  The verified constructs were 
transformed into S. stipitis FPL-UC7.  Transformants were selected on SC-Ura plates for 
3-5 days until colonies appeared.  For terminator characterization, a total of 15 
terminators of various lengths were amplified from S. stipitis FPL-UC7 genomic DNA, 
and co-transformed with the sTEF1p-egfp and the ble1-XYL2t fragments.  The ble1-
XYL2t fragment was amplified from the pJML545 backbone26 and the control random 




the shikimate pathway, genes (tkt1, aro4K220L and aro1D900A), promoters (sADH1p, 
sPIR1p, and UAGp), and terminators (sUAGt, sAOX1t, sOLE1t, PGK1t, ADH1t, and 
sPIR1t) were amplified from S. stipitis FPL-UC7 genomic DNA.  Site-directed 
mutagenesis was performed by overlap extension PCR (OE-PCR)49 to introduce the 
corresponding mutations into aro1 and aro4.  Expression cassettes (sADH1p-tkt1-
sUAGt, sPIR1p-aro4K220L-sAOX1t, and UAGp-aro1D900A-sOLE1t, or sADH1p-tkt1-
PGK1t, sPIR1p-aro4K220L-ADH1t, and UAGp-aro1D900A-sPIR1t) were constructed by 
OE-PCR and assembled into pMG1 linearized by XhoI and ClaI using the DNA 
assembler approach (Figure S3). 
3.2.3 Terminator characterization via qPCR 
Sixteen recombinant S. stipitis FPL-UC7 strains harboring 15 selected terminators 
and the non-functional control sequence were evaluated using qPCR.  Strains were grown 
on SC-Ura plates for 3 days, and single colonies were inoculated into 15 mL SC-Ura 
liquid media and grown until OD600 reached ~3.  The resulting cultures were transferred 
to 50 mL SC-Ura liquid media with an initial OD600~0.2.  Cell pellets with a total 
OD600~50 were collected at 24 hr and 48 hr and stored at -80°C.  Total RNA extraction 
and removal of DNA contamination were performed as described above.  cDNA libraries 
were generated by reverse transcription using a RevertAid first strand cDNA synthesis kit 
(ThermoScientific, Waltham, MA).  qPCR was performed on a StepOnePlus Real-Time 
PCR system (ThermoScientific, Waltham, MA).  Primers were designed using the free 
online PrimerQuest tool provided by Integrated DNA Technologies 
(https://www.idtdna.com/Primerquest/Home/Index).  qPCR reactions were carried out in 




appropriate volume, 1.25 μL 20 μM forward primer, and 1.25 μL 20 μM reverse primer.  
Thermal cycling conditions were as follows: initial denaturation, 1 cycle of 95°C for 20 s; 
amplification, 40 cycles of 95°C for 3 s, and 60°C for 30 s; and final dissociation, 1 cycle 
of 95°C for 15 s, 60°C for 15 s, and 95°C for 15 s.  Relative quantification of egfp and 
ble1 transcripts was determined using the corresponding standard curves followed by 
calculation of the ratio of egfp to ble1 transcripts for each cDNA library.  All assays were 
performed in triplicate. 
3.2.4 Promoter and terminator characterization using EGFP assay 
Recombinant S. stipitis FPL-UC7 strains carrying individual promoter-egfp-
terminator cassette were grown on synthetic complete (SC) without uracil (SC-Ura) 
plates for 3-4 days, and single colonies were inoculated into 250 mL baffled flasks 
(VWR, Chicago, IL) containing 25 mL SC-Ura liquid media and grown until OD600 
reached ~3.  The resulting cultures were transferred to 250 mL baffled flasks containing 
50 mL of one of the three specified liquid media (oxygen-rich condition), or to 100 mL 
serum bottles (VWR, Chicago, IL) containing 60 mL of one of the three specified liquid 
media (oxygen-limited condition) with initial OD600~0.2.  The specified media were SC-
Ura plus 1.4% glucose, SC-Ura plus 1.4% glucose and 0.6% xylose, and SC-Ura plus 
0.6% xylose.  Note that here sugar concentrations were reduced to 40% of those used in 
the RNA-seq experiment.  This was because SC medium instead of rich media were used 
to maintain plasmids, and the cells were not able to deplete 35 g/L glucose in the SC 
media during fermentation.  Baffled flasks were used with 250 rpm orbital shaking to 
maintain oxygen-rich conditions; serum bottles were used with 200 rpm orbital shaking 




and total EGFP intensity was measured on a 96-well black polystyrene plate (Fisher 
Scientific, Pittsburgh, PA) using a Synergy HTX multi-mode reader (BioTek, Winooski, 
VT).  The excitation and the emission wavelengthes were 485 nm and 516 nm, 
respectively.  
3.2.5 Shikimate production  
A single colony of S. stipitis FPL-UC7 harboring the three enzymes involved in 
the shikimate pathway was inoculated into 3 mL SC-Ura liquid media until OD600 
reached ~3.  Cells were washed three times with water, transferred to 50 mL SC-Ura 
liquid media with an initial OD600~0.2, and cultivated at 30°C with 250 rpm orbital 
shaking.  Samples were collected every 24 hr.  After centrifugation at 12,000-rpm for 10 
min, the supernatant was filtered through a 0.2 μm syringe filter (XPERTEK, St. Louis, 
MO) prior to HPLC analysis.  Waters HPLC system (Waters, Milford, MA) was 
equipped with a binary HPLC pump, a 717plus auto sampler, a column heater module, 
and a 2998 photodiode array detector, and an Aminex HPX-87H column (300×7.8 mm) 
(Bio-Rad, Hercules, CA).  The HPLC program was as follows: flow rate, 0.3 mL/min; 
column temperature, 30°C; sample size, 10 μL; mobile phase, 5 mM sulfuric acid; and 
running time, 60 min/sample.  PDA data extracted at 210 nm were compared to a 






3.3 Results and Discussion 
3.3.1 Strain selection and pathway design 
Despite the fact that shikimate serves as an important intermediate in the aromatic 
amino acid biosynthetic pathways of many organisms, its accumulation in yeast species 
has not been reported to date.  Considering that the two precursors of the shikimate 
pathway, phosphoenolpyruvate (PEP) and erythrose-4-phosphate (E4P), originate from 
the glycolytic pathway and the pentose phosphate pathway, respectively (Figure 1a), we 
hypothesized that the highly active xylose-consuming species, S. stipitis, might be a 
better production host than the regular glucose-utilizing yeasts due to the fact that it has a 
more active pentose phosphate pathway16, 17.  In yeasts, the entry into the shikimate 
pathway via condensation of PEP and E4P is governed by two isozymes of 3-deoxy-D-
arabino-heptulosonate-7-phosphate (DAHP) synthase (encoded by aro3 and aro4), which 
are subject to feedback inhibition by aromatic amino acids.  It has previously been shown 
that overexpressing a tyrosine-insensitive aro4K229L mutant in an aro3/aro4 double 
knockout strain successfully alleviated this feedback inhibition in S. cerevisiae18.  In 
addition, as evidenced by the production of muconic acid that utilizes 3-dehydro-
shikimate (DHS) as its synthetic precursor19, 20, overexpression of the transketolase gene 
(tkt1) in S. cerevisiae contributed an increased flux in the pentose phosphate pathway, 
consequently improving muconic acid production by increasing the E4P supply (Figure 
1a). 
To increase the production of shikimate, the flux towards shikimate must be 
enhanced, but its subsequent conversion to shikimate-3-phosphate (S3P) must be halted.  




ARO1 catalyzes the five steps that convert DAHP to 5-enolpyruvylshikimate-3-
phosphate (EPSP)21.  Sequence alignment with shikimate kinase genes from prokaryotes 
and fungi indicates that the aspartate (Asp) at position 900 is the conserved active site in 
the shikimate kinase subunit of ARO1, corresponding to Asp36 in E. coli AroK (Figure 
S1)22.  We hypothesized that substitution of Asp900 with alanine would significantly 
boost shikimate accumulation, without affecting the other catalytic functions of the 
ARO1 subunits.  
3.3.2 Identification of strong constitutive promoters via transcriptome analysis  
Although S. stipitis has great potential in the biorenewables field due to its natural 
capability for xylose fermentation, its broader application as a popular host is limited by a 
lack of genetic manipulation tools.  As a first step to develop a highly productive strain, 
we sought to identify strong constitutive promoters using RNA-seq.  Promoters such as 
TEF1p, Xyl1p, ADH1p and ADH2p have been used to drive gene expression in S. stipitis 
in independent studies23-26, but no systematical comparison and characterization have 
been performed.  Previous transcriptomic studies (i.e. DNA microarray) in S. stipitis 
chose single-sugar (glucose or xylose) conditions and analyzed only one time point 
during the exponential phase27, 28.  In the current study, the strong potential of S. stipitis 
for use as an industrial producer to convert biomass-derived sugars led us to choose 
mixed-sugar plus industry-preferred oxygen-limited condition to culture the strain.  The 
culture was sampled at three defined time points (15, 48, and 72 hr).  The absolute counts 
for ~5700 genes were normalized using the upper quartile method29, and more than 94% 
of all reads were uniquely mapped to the reference genome for S. stipitis (v2.0 






Figure 1. (a) Biosynthetic pathways of shikimate and its derivatives.  Metabolites: E4P, 
erythrose-4-phosphate; PEP, phosphoenolpyruvate; DAHP, 3-deoxy-D-arabino-
heptulosonate-7-phosphate; DHQ, 3-dehydroquinic acid; DHS, 3-dehydroshikimate; S3P, 
shikmate-3-phosphate; EPSP, 5-enolpyruvylshikimate-3-phosphate; CHA, chorismate; 
PPA, prephenic acid; TRP, tryptophan; PHE, phenylalanine; TYR, tyrosine; QA, quinic 
acid; PCA, protocatechuate; MA, muconic acid; IAA, indole-3-acetic acid.  Enzymes: 
Aro4K229L, DAHP synthase mutant insensitive to feedback inhibition; Aro1D900A, adapted 
pentafunctional enzyme variant with shikimate kinase domain inactivated; TKL, 
transketolase.  (b) (adapted from reference10) Bioactive products derived from shikimate.  
(-)-zeylenone, a polyoxygenated cyclohexane with antiviral, anticancer, and antibiotic 
activities; (-)-valiolamine with inhibitory activity against porcine intestinal sucrase, 
maltase, and isomaltase; 3,4-oxo-isopropylidene-shikimate with antithrombotic, anti-
adhesion, anti-inflammatory activity; oseltamivir with anti-influenza virus activity; 
[Pt(datch)(shikimate)2], active against L1210 leukemia; analogs of 1α, dihydroxy-19-




Constitutively and highly expressed genes were selected based on two criteria.  
First, the transcriptional level of a specific gene should be above the level of tef1 at both 
sampling time points (48 and 72 hr).  This criterion was based on the fact that after 48 hr, 
glucose was nearly depleted and xylose became the main carbon source (Figure S2).  A 
total of 23 genes were discovered, after which a second threshold was applied to select 
genes with at least a 2-fold higher expression compared to that of tef1 at 15 hr.  Due to 
carbon catabolite repression (CCR), only glucose was utilized during the first 15 hr.  For 
effective co-sugar conversion, the activities of the desired promoters should not vary 
significantly with the transition of the sugar option or with sugar concentration.  As a 
result, nine highly expressed genes were identified (Figure 2a and Table S2), and their 
promoters and terminators were isolated for more detailed characterization.  
3.3.3 Promoter characterization and length optimization  
The genomic context of the ten selected promoters (including TEF1p) is 
summarized in Figure 2b.  According to the transcriptional direction of neighboring 
genes, five of the ten upstream intergenic regions contain the terminators of the upstream 
genes, while each of the other five regions carries another promoter that runs in the 
reverse direction.  It was challenging to identify the promoter boundaries initially; 
therefore we began by tagging the entire intergenic region (1.1 to 2.6 kb) with an egfp 
reporter gene encoding enhanced green fluorescence protein (EGFP) and the same 
terminator (TEF1t).  The EGFP output of the resulting ten strains grown in mixed-sugar 
oxygen-limited condition was evaluated (Figure 3a).  Largely consistent with RNA-seq 






Figure 2. (a) Absolute mRNA reads from ten highly expressed genes selected from S. 
stipitis FPL-UC7 based on RNA-seq analysis.  Error bars represent standard deviations of 





In particular, ADH1p and UAGp showed the highest activity, more than 7-fold stronger 
than TEF1p (for individual promoters, the time points giving the highest activities were 
selected for comparison).  Only AOX1p appeared weaker than TEF1p.  This could be 
attributed to the difference in mRNA stability when the native gene and terminator were 
replaced by egfp and TEF1t30.   
Next, we truncated the 5’-ends of the intergenic promoters so that only 500-800 
bp from the 3’-end remained.  When these shortened promoters were evaluated under the 
same mixed-sugar oxygen-limited condition (Figure 3b), the majority maintained 
stronger activities than the shortened TEF1p (sTEF1p).  When compared with their 
intergenic counterparts, six of the shortened promoters (sADH1p, sENO1p, sPIR1p, 
sTDH2p, sAOX1p, and sTEF1p) displayed 1.5- to 3.2-fold higher activities, whereas the 
other four (sUAG1p, sGLN1p, sOLE1p, and sPGK1p) maintained 0.9-1.4 fold strengths 
to the full-length promoters.  The enhanced strengths seen with the shortened promoters 
suggest that the deleted regions may have contained repressor-binding sites.  We also 
noticed that although sUAGp produced a strong signal, the EGFP expression peak 
verified by flow cytometry analysis was abnormally broad (data not shown), indicating 
potential instability of the plasmid.  The full-length intergenic promoter was therefore 
selected for UAGp.  Sequences of the nine shortened promoters and the intergenic UAGp 
are summarized in Table S3.  This collection of strong promoters will be useful for 







Figure 3. EGFP intensity of S. stipitis FPL-UC7 harboring the egfp gene cloned 
downstream of each of the 10 selected promoters, under mixed-sugar oxygen-limited 
condition.  (a) intergenic promoters and (b) shortened promoters.  All data were 





3.3.4 Terminator discovery and characterization 
In addition to intensive promoter characterization and engineering, recent 
attention has been broadened to terminators due to their essential function as 
transcriptional modulators via the control of mRNA stability and half-life32,33,34.  
Therefore, the terminator regions of the ten highly expressed genes previously identified 
from RNA-seq (Figure 2a) were selected for detailed characterization at both 
transcriptional and translational levels.  Again, the genomic context revealed that five 
intergenic terminator regions (ADH1t, PIR1t, TEF1t, ENO1t, and PGK1t) contained 
another terminator running in the opposite direction (Figure 2b).  For this group, if the 
length was shorter than 500 bp, the intergenic region was left intact; otherwise, the first 
500 bp was selected as the putative terminator.  The other five intergenic terminator 
regions (AOX1t, GLN1t, UAGt, OLE1t, and TDH2t) include the promoters of 
neighboring genes, which could interfere with the downstream gene transcription if the 
entire region was selected as the terminator, therefore two sequence lengths of 150 bp 
and 300 bp were chosen for further verification.  To verify termination efficiency, we 
devised a method that utilizes two reporter genes, egfp and ble1 (Figure 4a).  The putative 
terminator was inserted between the two reporter genes, which share a common promoter 
(sTEF1p) and terminator (XYL2t).  In principle, if the inserted sequence is not functional, 
the two reporter genes will be co-transcribed, and thus the transcription ratio of ble1 to 
egfp should be close to 1.  Conversely, if a strong terminator is inserted, the ratio will be 
close to 0.  Accordingly, the transcription ratio for each construct carrying a putative 
terminator or a random, non-functional sequence was calculated using real-time PCR 




control construct (a random sequence inserted between the two reporter genes).  This 
result not totally unexpected when considering the bias towards the 3’ end of mRNA 
during reverse transcription using oligo(dT)s as a primer32, 35.  The ratio for the positive 
control, TEF1t, was very close to zero, indicating that transcription read through was 
minimal.  For AOX1t, GLN1t, UAGt, and OLE1t, the 150 bp versions presented low 
transcription termination abilities with ratios of at least 1.  The 300 bp lengths were 
therefore selected for these four terminators, named correspondingly as sAOX1t, 
sGLN1t, sUAGt, and sOLE1t.  The transcription ratios of the remaining terminators 
ranged from 0.003 to 0.21, therefore qualifying them as strong terminators to efficiently 
block transcription.  The strains carrying these tailored terminators were then cultured 
under the mixed-sugar oxygen-limited condition.  According to EGFP intensity, the 
strengths of the terminators ranged from 0.07- to 0.7-fold with respect to TEF1t, and of 
these newly discovered terminators, sUAGt was 9.6-fold stronger than the weakest 
terminator ENO1t (Figure 4c).  These results demonstrate that, as for promoter selection, 
choosing an appropriate terminator is also important for modulating gene expression to 
optimize metabolic pathways.  The optimized terminator lengths and sequences are 
summarized in Table S3. 
3.3.5 Shikimate production in S. stipitis  
Based on the characterization described above, the strong promoters (sADH1p, 
UAGp and sPIR1p) and terminators (sAOX1t, sUAGt, and sOLE1t) were subsequently 
used to reconstitute the shikimate pathway in S. stipitis FPL-UC7.  The recombinant 




terminator (Figure S3), was first cultured under mixed-sugar oxygen-limited condition, 
leading to shikimate production at a titer of 0.30 ± 0.10 g/L after 120 hr of fermentation 
 
 
Figure 4. (a) Diagram of constructs used to test terminator efficiency.  The target 
terminator is located between two reporter genes, egfp and ble1.  If the terminator has 
high termination efficiency, the transcript ratio of ble1 to egfp should be close to 0.  If the 
target sequence is not functional, the ratio should theoretically be 1.  (b) Termination 
efficiency of the selected terminators at the transcriptional level.  (c) Terminator 
characterization based on EGFP intensity.  S. stipitis FPL-UC7 harboring the egfp gene 
upstream of each of the 10 select terminators, cultured under mixed-sugar oxygen-limited 




(construct 2.1 in Figure 5).  Interestingly, although the strong promoters and terminators 
were identified using the mixed-sugar oxygen-limited condition, their strengths were 
maintained under other commonly used laboratory conditions.  As shown in Figure 6a, 
the selected promoters and terminators, together with sTEF1p and TEF1t, were evaluated 
in single-sugar (glucose or xylose) or mixed-sugar in combination with oxygen-rich or 
oxygen-limited conditions.  The promoter sPIRp drove a constitutive EGFP expression 
under all six conditions, roughly independent of oxygen level or sugar  option; sADH1p 
appeared to be oxygen-sensitive, although even in the presence of oxygen the EGFP 
intensity was still similar to that of sTEF1p; and UAGp demonstrated a preference on 
xylose-containing media in the oxygen-limited condition.  Moreover, except that sAOX1t 
and TEF1t demonstrated a preference on glucose oxygen-rich condition and xylose 
oxygen-rich condition, respectively, the variation of the EGFP intensity associated with 
the four terminators in different culture conditions was minimal (Figure 6b).  However, 
shikimate production levels varied strongly, with the highest titers of 2.83 ± 0.04 and 
2.93 ± 0.04 g/L achieved under the mixed-sugar oxygen-rich condition and the pure 
glucose oxygen-rich fermentation, respectively (Figure 5).  The implications of shikimate 
production preference on fermentation conditions are varied strongly, with the highest 
titers of 2.83 ± 0.04 and 2.93 ± 0.04 g/L achieved under the mixed-sugar oxygen-rich 
condition and the pure glucose oxygen-rich fermentation, respectively (Figure 5).  The 
implications of shikimate production preference on fermentation conditions are varied 
strongly, with the highest titers of 2.83 ± 0.04 and 2.93 ± 0.04 g/L achieved under the 
mixed-sugar oxygen-rich condition and the pure glucose oxygen-rich fermentation, 







Figure 5. Shikimate production under various culture conditions.  Construct 2.1: 
sADH1p-tkt1-sUAGt, sPIR1p-aro4K220L-sAOX1t, and UAGp-aro1D900A-sOLE1t; 
Construct 7.3: sADH1p-tkt1-PGK1t, sPIR1p-aro4K220L-ADH1t, and UAGp-aro1D900A-
sPIR1t.  -O2, oxygen-limited; +O2, oxygen-rich; G, 4% glucose; GX, 2.8% glucose plus 








Figure 6. Characterization of the selected promoters (a) and terminators (b) under six 
culture conditions.  Abbreviations: -O2, oxygen-limited; +O2, oxygen-rich; G, 1.4% 
glucose; GX, 1.4% glucose plus 0.6%  xylose; X, 0.6% xylose. 
 
 
fermentation conditions are two-fold: (1) regardless of the sugar option, PEP and E4P 




conditions, resulting in significantly higher production titers when the oxygen supply was 
sufficient, even though enzyme expression might prefer oxygen-limited conditions; (2) 
the mixed-sugar (2.8% glucose+1.2% xylose) condition did not produce titers above 
those seen with 4% glucose conditions, at both oxygen levels which was mainly due to 
CCR.  At this stage, precursor availability rather than enzyme expression seems to be the 
rate-limiting parameter for shikimate production: a slightly higher titer (3.11 ± 0.19 g/L, 
Figure 5) was observed even after replacing the three strong terminators with three 
medium-level terminators (PGK1t, ADH1t, and sPIRt, Figure S3).  Nevertheless, to the 
best of our knowledge, this platform could potentially permit production of much higher 
levels of shikimate pathway products compared to those achieved with any other yeast 
platforms to date (Table S1).   
Despite a clear discrepancy between the two conditions that produced shikimate 
at the highest titer and that provided the strongest promoter activities, the data from the 
current study suggest that future work to improve shikimate production should be focused 
on improving precursor availability and balancing pathway expression.  Although the 
promoter and terminator pairs were identified from the mixed-sugar oxygen-limited 
condition, their activities were stronger or at least comparable to those of sTEF1p and 
TEF1t standards under glucose oxygen-rich conditions.  This observation raises an 
interesting question—whether those very strong promoters and terminators are even 
needed, especially considering the extra energy burden involved in gene overexpression.  
An abundance of evidence from previous studies suggests that, in order to achieve 
balanced pathway expression, it is much easier to mutagenize strong promoters and tailor 




success has been achieved using this method to improve isoprenoid production36, 37, and 
boost xylose and cellobiose utilization efficiency38, 39.  The combination of promoters and 
terminators of various strengths, therefore, provides a great opportunity to modulate the 
expression of individual genes in a pathway.  Considering the lack of a comprehensive 
evaluation of promoters and terminators that are applicable in S. stipitis, we further 
performed a systematic characterization of all the newly isolated promoters and 
terminators in the six routinely used culture conditions (Figure S6 and S7), which 
provides a valuable resource for designing biosynthetic pathways and modulating gene 
expression in S. stipitis. 
Many nonconventional microorganisms have highly desirable biosynthetic and 
metabolic features that are not shared by model hosts.  Recent advances in platform 
technologies such as CRISPR-Cas940 and next-generation sequencing41 have catalyzed a 
growing interest in exploring nonconventional organisms as microbial factories.  In the 
current study, we demonstrate that S. stipitis would be particularly well suited to produce 
shikimate derivatives, compared to the relatively low yields achieved in S. cerevisiae.  
However, even in S. stipitis, the main factor that prohibits a high production level is the 
limited availability of PEP and E4P.  Future work will be focused on relieving CCR in 
order to synchronize glycolysis and pentose phosphate pathway, mainly for the purpose 
of increasing the E4P level.  Replacing the promoters of the genes sensitive to CCR with 
the constitutive promoters isolated from the mixed-sugar condition might relieve CCR on 
the transcriptional level.  A fully resolved CCR would also involve the incorporation of 
xylose transporters that are not sensitive to glucose.  Furthermore, to increase PEP level, 




(pyruvate kinase) with an inducible one or expressing a mutant pyk with reduced activity 
to retain flux for the reaction catalyzed by Aro4K220L; (2) overexpressing ppck (PEP 
carboxykinase) and pc (pyruvate carboxylase) to recirculate pyruvate to PEP.  Both 
strategies have been demonstrated with some success in bacteria42-44, and the former will 
rely on the ongoing development of CRISPR-Cas9 technology to achieve genome-
specific modification.  This, however, has been challenging for nonconventional 
organisms with high non-homologous end joining efficiency.  Nevertheless, our work 
represents advances into expanding the current collection of microbial factories and 
emphasizes the rationale for selecting a host that is best suited to producing a particular 
group of compounds. 
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3.5 Supplementary Information 
3.5.1 Supplementary methods  
3.5.1.1 Strains and Media 
S. cerevisiae YSG50 (MATα, ade2-1, ade3Δ22, ura3-1, his3-11, 15, trp1-1, leu2-
3, 112, and can1-100) was used as the host for pathway assembly1-3.  E. coli WM1788 
was used for the enrichment of all plasmids.  S. stipitis FPL-UC7 (ura3-3) was a gift from 




YSG50 and S. stipitis FPL-UC7 were grown in YPA plus 2% glucose (YPAD) media and 
their recombinant strains were selected in synthetic complete (SC) medium unless 
otherwise stated.  YPA is composed of 10 g/L yeast extract, 20 g/L peptone, and 100 
mg/L adenine hemisulfate.  SC medium contains 1.7 g/L yeast nitrogen base, 5 g/L 
ammonium sulfate, 43.3 mg/L adenine hemisulfate, and 20 g/L glucose unless otherwise 
stated.  In addition, depending on the auxotrophic type, SC medium was supplemented 
with either amino acid mix CSM-Trp or CSM-Ura (MP medicals, San Diego, CA), and 
the amount was calculated according to the manufacturer’s instruction, resulting in SC-
Trp or SC-Ura medium.  Both S. cerevisiae YSG50 and S. stipitis FPL-UC7 were grown 
at 30°C with 250 rpm orbital shaking.  E. coli WM1788 was propagated in Luria-Bertani 
(LB) liquid media containing 100 μg/mL ampicillin at 37°C with 250 rpm orbital 
shaking.   
3.5.1.2 RNA-seq  
The RNA integrity number (RIN) was tested using an Agilent RNA 6000 Nano 
kit (Agilent, Santa Clara, CA) and an Agilent 2100 Bioanalyzer (Agilent, Santa Clara, 
CA) for the analysis and quantification of total RNA samples.  Samples with an RIN 
greater than 8.0 were submitted to the DNA facility at Iowa State University.  An 
Illumina TruSeq RNA sample prep kit v.2 (Illumina, San Diego, CA) was used to 
generate barcoded cDNA libraries.  All libraries were then pooled onto two lanes of the 
flow cell and clusters were generated using a TruSeq rapid cluster kit (Illumina, San 
Diego, CA).  Sample sequencing was done on an Illumina Hiseq 2500 (Illumina, San 
Diego, CA) with a 50-cycle rapid run mode using a TruSeq Rapid SBS kit (Illumina, San 
Diego, CA).  Approximately 259 million 100 bp paired-end reads were obtained after 




(http://www.bioinformatics.babraham.ac.uk/projects/fastqc/) for all the samples.  The 
paired-end reads were then mapped against the GSNAP indexed reference genome Pichia 
stipitis (v2.0)5 downloaded from JGI.  GSNAP (v 2014-01-21)6 was used for mapping 
using default parameters, with a maximum of five allowed mismatches, allowing splice 
site mapping.  HTSeq (v 0.6.0)7 was used to generate raw read counts from each sample 
for each gene feature using uniquely mapped reads and known S. stipitis annotations.  
Counts for each sample were merged using an AWK script, and differential gene 
expression analysis was carried out using QuasiSeq (v1.0-4)8.  Absolute counts for all 
genes from different libraries were normalized using the upper quartile method9.  
Normalized values were subsequently used to rank gene transcription levels within 
mixed-sugar samples from the highest to the lowest. 
3.5.1.3 Stepping into oseltamivir phosphate synthesis 
The relatively high titer of shikimate encouraged us to begin to investigate 
downstream processes including product recovery and further derivatization.  
Sequentially passing the cell-free medium through activated carbon, an anion-exchange 
resin, and a cation-exchange resin resulted in a shikimate purity of 81% (Figure S4).  We 
then attempted the first two steps of oseltamivir phosphate synthesis according to the 
process developed by Roche (Figure S5)11.  The 81% pure shikimate was first esterified 
to ethyl shikimate in the presence of ethanol and thionyl chloride.  Without further 
purification, the crude ethyl shikimate was treated with 2,2-dimethoxypropane in the 
presence of catalytic p-toluenesulfonic acid to form ethyl 3,4-O-isopropylidene 
shikimate, giving a final yield of 97% (based on 81% purity shikimate) over two steps 




synthesize this key intermediate with simple procedures in such a high yield and purity 
indicates a feasible process of implementing yeast-produced shikimate for Tamiflu 
production. 
3.5.1.4 Shikimate purification 
Shikimate was recovered from the cell-free S. stipitis fermentation broth by a 
multi-step process based on previously described methods10.  To purify the shikimate, the 
cell-free broth was first adjusted to pH 8.5 with concentrated ammonium hydroxide and 
passed through a bed of NORIT CN1 activated carbon.  High purity 18.2 megohm-cm 
water was used to wash out the remaining shikimate.  The filtrate and wash from the 
activated carbon bed were pooled and adjusted to pH 2.0 using concentrated HCl.  The 
shikimate pool was then captured on a DOWEX 1X8 anion exchange resin column 
(Sigma-Aldrich, St. Louis, MO) in the acetate form and washed with 10 mM acetic acid 
to get rid of non-binding contaminants.  500 mM acetic acid was used to elute the 
shikimate off of the DOWEX 1X8 column.  The shikimate containing eluate from the 
anion exchange column was flowed through a DOWEX 50WX8 cation exchange resin 
column (Sigma-Aldrich, St. Louis, MO) in the hydrogen form.  High purity 18.2 
megohm-cm water was again used to wash out the remaining shikimate.  At this point, a 
dried shikimate sample had a yield greater than 95%, but had the purity of only 81%.  
Reaction tests on this dried material yielded ethyl 3, 4-O-isopropylidene shikimate at 
97% in the initial reaction pathway to Tamiflu®.  The post cation exchange column 
material can alternatively be concentrated in a rotatory evaporator and crystallized in 
methanol to a high purity (>99%).  Unfortunately, the overall yield was sacrificed in the 




step was not necessary for the use of shikimate in Tamiflu® synthesis, high purity 
shikimate via crystallization may be useful for other chemical conversions.  
3.5.1.5 Conversion of shikimate to ethyl 3, 4-O-isopropylidene shikimate 
(This part of work was performed by Dr. James Walker in Dr. Levi Stanley’s group at 
ISU through collaboration) 
SOCl2 (42 µL, 0.57 mmol) was added in a drop-wise fashion to a stirred 
suspension of 81% pure (verified by HPLC analysis, 4.48 mmol/g) (-)-shikimate ((3R, 
4S, 5R)-3,4,5-trihydroxycyclohex-1-ene-1-carboxylic acid) (100 mg, 0.448 mmol) in 
ethanol (0.57 mL) at room temperature.  During the addition of SOCl2, the temperature of 
the reaction increased from room temperature to ~35°C.  After the addition of SOCl2, the 
reaction mixture was heated at reflux.  After 3 hr, the reaction mixture was cooled to 
room temperature and concentrated under reduced pressure.  The resulting crude ethyl 
shikimate was used in the next step without further purification.  Ethyl acetate (3 mL), 2, 
2-dimethoxypropane (71 µL, 0.57 mmol), and p-toluenesulfonic acid monohydrate (1 
mg, 0.006 mmol) were added to the crude ethyl shikimate.  The reaction mixture was 
warmed to 35°C and stirred for 2 hr, after which the initial volume was decreased to 
approximately half the original volume under reduced pressure.  A second equivalent of 
2, 2-dimethoxypropane (71 µL, 0.57 mmol) was added to the reaction, and the reaction 
was stirred at 35 °C for an additional 2 hr.  The reaction mixture was cooled to room 
temperature and evaporated to dryness under reduced pressure.  Crude ethyl 3, 4-O-
isopropylidene shikimate was purified by flash column silica gel chromatography with 
CH2Cl2 as the eluent.  Pure ethyl 3, 4-O-isopropylidene shikimate was isolated as 




J = 7.2 Hz, 3H), 1.41 (s, 3H), 1.46 (s, 3H), 2.23 (ddt, J = 17.2, 8.4, 2 Hz, 1H), 2.73-2.81 
(s, 1H), 2.78 (dd, J = 17.2, 4.4 Hz, 1H), 3.89 (td, J = 8.0, 4.8 Hz, 1H), 4.10 (m, 1H), 4.22 
(q, J = 7.2 Hz, 2 H), 4.76 (m, 1H), 6.93 (m, 1H).  13C NMR (101 MHz, CDCl3) d 14.2, 






3.5.2 Supplementary tables 
 
Table S1. Production of shikimate derivatives in S. cerevisiae. 
 
 Compounds Titers References 
muconic acid 559.5 mg/L 11 
trans-resveratrol 0.31 mg/L 12 
genistein 7.7 mg/L 12 
kaempferol 4.6 mg/L 12 
quercetin 0.38 mg/L 12 
naringenin 113 mg/L 13 
(R, S)-reticuline 150 mg/L 14 
artemisinin 100 mg/L 15 
thebaine 6.4 μg/L 16 
hydrocodone 0.3 μg/L 16 
p-coumaric acid 1.93 g/L* 17 
* Produced by fed-batch fermentation; others 




Table S2.  Ten selected constitutive genes expressed at high levels in the mixed-sugar oxygen-limited condition. 
 
 
Gene Protein ID 
Intergenic 











ADH1 68558 1463 544 357 357 alcohol dehydrogenase, class v 
AOX1 67332 2333 574 1079 300 
alternative oxidase, mitochindrial 
precursor 
ENO1 70720 1434 570 233 233 enolase 
GLN1 68474 2090 532 2560 300 glutamine syntetase 
UAG 83546 1582 579 2897 300 hypothetic protein  
PGK1 78267 1515 526 150 150 3-phosphoglycerate 
PIR1 81594 1819 792 715 500 
protein containing tandem internal 
repeats 
OLE1 70693 2609 561 2285 300 fatty acid desaturase 
TDH2 85794 1103 552 1292 300 
glyceraldehyde 3-phosphate 
dehydrogenase 
TEF1 65303 1622 596 329 329 






Table S3. The sequences of the strong constitutive promoters and terminators. 
 






















































































































Table S3. (continued) 
 


































































Figure S1. (adapted from reference18) Bioactive products derived from shikimate.  (-
)-zeylenone, a polyoxygenated cyclohexane with antiviral, anticancer, and antibiotic 
activities; (-)-valiolamine with inhibitory activity against porcine intestinal sucrase, 
maltase, and isomaltase; 3,4-oxo-isopropylidene-shikimate with antithrombotic, anti-
adhesion, anti-inflammatory activity; oseltamivir with anti-influenza virus activity; 
[Pt(datch)(shikimate)2], active against L1210 leukemia; analogs of 1α, dihydroxy-19-








Figure S2. Sequence alignment of shikimate kinases from different species. Ec, E. 
coli; Dz, Dickeya zeae; Sp, Schizosaccharomyces pombe; Ss, S. stipitis; Sc, S. 











Figure S3. The growth and sugar consumption of S. stipitis cultured in YPA plus 
3.5% glucose (a), YPA plus 3.5% glucose and 1.5% xylose (b), and YPA plus1.5% 
xylose (c).  Initial OD600 was at ~0.2.  Error bars represent the standard deviations of 















Figure S5. 1H NMR spectra in DMSO-d6 of shikimate from fermentation broth after 
individual separation steps.  (a) Filtered through a bed of activated carbon.  (b) Bound 
to and eluted from a column containing an anion exchange resin.  (c) Filtered through 
a column containing a cation exchange resin.  (d) Concentrated by rotary evaporation 
and crystallized in methanol.  Purity values were obtained though liquid 













Figure S6. (a) Formal synthesis of oseltamivir phosphate from shikimate.  (b) 1H 
NMR spectra for ethyl 3, 4-O-isopropylidene shikimate.  (c) 13C NMR spectra for 




























































































































































4 Pulse Sequence s2pul
5 Experiment 1D
6 Probe OneNMR_W024
7 Number of Scans 8
8 Receiver Gain 12
9 Relaxation Delay 1.0000
10 Pulse Width 0.0000
11 Spectrometer Frequency 399.69
12 Spectral Width 6410.3
13 Lowest Frequency -788.1
14 Nucleus 1H
15 Acquired Size 16384
































































4 Pulse Sequence s2pul
5 Experiment 1D
6 Probe OneNMR_W024
7 Number of Scans 256
8 Receiver Gain 30
9 Relaxation Delay 1.0000
10 Pulse Width 0.0000
11 Spectrometer Frequency 100.51
12 Spectral Width 25510.2
13 Lowest Frequency -1689.2
14 Nucleus 13C
15 Acquired Size 32768











Figure S7. Characterization of the shortened promoters in six lab-routinely-used 
culture conditions.  (a) mixed-sugar (1.4% glucose plus 0.6% xylose) oxygen-limited 
condition; (b) mixed-sugar (1.4% glucose plus 0.6% xylose) oxygen-rich condition;  
(c) pure glucose (1.4%) oxygen-rich condition; (d) pure glucose (1.4%) oxygen-
limited condition; (e) pure xylose (1.4%) oxygen-rich condition; (f) pure xylose 
(0.6%) oxygen-limited condition.  All data were normalized by OD600.  Error bars 







Figure S8. Characterization of the shortened terminators in six lab-routinely-used 
culture conditions.  (a) mixed-sugar (1.4% glucose plus 0.6% xylose) oxygen-limited 
condition; (b) mixed-sugar (1.4% glucose plus 0.6% xylose) oxygen-rich condition;  
(c) pure glucose (1.4%) oxygen-rich condition; (d) pure glucose (1.4%) oxygen-
limited condition; (e) pure xylose (0.6%) oxygen-rich condition; (f) pure xylose 
(0.6%) oxygen-limited condition.  All data were normalized by OD600.  Error bars 







[1] Shao, Z., and Zhao, H. (2012) DNA assembler: a synthetic biology tool for 
characterizing and engineering natural product gene clusters, Methods 
Enzymol. 517, 203-224. 
[2] Shao, Z., and Zhao, H. (2013) Construction and engineering of large biochemical 
pathways via DNA assembler, Methods Mol. Biol. 1073, 85-106. 
[3] Shao, Z., and Zhao, H. (2014) Manipulating natural product biosynthetic pathways 
via DNA assembler, Current Protocols in Chemical Biology 6, 65-100. 
[4] Jeffries, T. W. (2008) Engineering the Pichia stipitis genome for fermentation of 
hemicellulose hydrolysates, Bioenergy, 37-47. 
[5] Jeffries, T. W., Grigoriev, I. V., Grimwood, J., Laplaza, J. M., Aerts, A., Salamov, 
A., Schmutz, J., Lindquist, E., Dehal, P., Shapiro, H., Jin, Y. S., Passoth, V., 
and Richardson, P. M. (2007) Genome sequence of the lignocellulose-
bioconverting and xylose-fermenting yeast Pichia stipitis, Nat. Biotechnol. 25, 
319-326. 
[6] Wu, T. D., and Watanabe, C. K. (2005) GMAP: a genomic mapping and 
alignment program for mRNA and EST sequences, Bioinformatics 21, 1859-
1875. 
[7] Anders, S., Pyl, P. T., and Huber, W. (2015) HTSeq--a Python framework to work 
with high-throughput sequencing data, Bioinformatics 31, 166-169. 
[8] Lund, S., and Qu, L. (2014) QuasiSeq: Analyzing RNA sequence count tables 
using quasi-likelihood. 
[9] Bullard, J. H., Purdom, E., Hansen, K. D., and Dudoit, S. (2010) Evaluation of 
statistical methods for normalization and differential expression in mRNA-Seq 
experiments, BMC Bioinf. 11, 94. 
[10] Bochkov, D. V., Sysolyatin, S. V., Kalashnikov, A. I., and Surmacheva, I. A. 
(2012) Shikimic acid: review of its analytical, isolation, and purification 
techniques from plant and microbial sources, J. Chem. Biol. 5, 5-17. 
[11] Suastegui, M., Matthiesen, J. E., Carraher, J. M., Hernandez, N., Rodriguez 
Quiroz, N., Okerlund, A., Cochran, E. W., Shao, Z., and Tessonnier, J. P. 
(2016) Combining metabolic engineering and electrocatalysis: Application to 
the production of polyamides from sugar, Angew. Chem., Int. Ed. Engl. 55, 
2368-2373. 
[12] Trantas, E., Panopoulos, N., and Ververidis, F. (2009) Metabolic engineering of 
the complete pathway leading to heterologous biosynthesis of various 
flavonoids and stilbenoids in Saccharomyces cerevisiae, Metab. Eng. 11, 355-
366. 
[13] Koopman, F., Beekwilder, J., Crimi, B., van Houwelingen, A., Hall, R. D., 





production of the flavonoid naringenin in engineered Saccharomyces 
cerevisiae, Microb. Cell Fact. 11, 155. 
[14] Hawkins, K. M., and Smolke, C. D. (2008) Production of benzylisoquinoline 
alkaloids in Saccharomyces cerevisiae, Nat. Chem. Biol. 4, 564-573. 
[15] Ro, D. K., Paradise, E. M., Ouellet, M., Fisher, K. J., Newman, K. L., Ndungu, J. 
M., Ho, K. A., Eachus, R. A., Ham, T. S., Kirby, J., Chang, M. C., Withers, S. 
T., Shiba, Y., Sarpong, R., and Keasling, J. D. (2006) Production of the 
antimalarial drug precursor artemisinic acid in engineered yeast, Nature 440, 
940-943. 
[16] Galanie, S., Thodey, K., Trenchard, I. J., Interrante, M. F., and Smolke, C. D. 
(2015) Complete biosynthesis of opioids in yeast, Science 349, 1095-1100. 
[17] Rodriguez, A., Kildegaard, K. R., Li, M., Borodina, I., and Nielsen, J. (2015) 
Establishment of a yeast platform strain for production of p-coumaric acid 
through metabolic engineering of aromatic amino acid biosynthesis, Metab. 
Eng. 31, 181-188. 
[18] Martinez, J. A., Bolivar, F., and Escalante, A. (2015) Shikimic acid production in 
Escherichia coli: From classical metabolic engineering strategies to omics 





CHAPTER 4 DISCOVERY OF NOVEL XYLOSE AND SHIKIMATE 
TRANSPORTERS TO FACILITATE MICROBIAL CONSORTIUM DESIGN AS 
A CHASSIS TO PRODUCE BENZYLISOQUINOLINE ALKALOIDS 
To be submitted to Nature Chemical Biology 
Abstract 
Plant-sourced aromatic amino acid (AAA) derivatives are an enormous group of 
compounds that have broad applications in the fields of food additives, nutraceuticals and 
pharmaceuticals. Regardless of their vast chemical diversity, the traditional plant-based 
extraction process is cumbersome and costly, whereas the chemical synthesis is retarded 
by the compounds’ complex structures associated with unique stereochemistry. Microbial 
synthesis of AAA derivatives, therefore, holds promise as a cost-effective alternative. 
Here we report the development of yeast consortia consisting of two species for efficient 
production of plant-specialized AAA derivatives. A novel xylose-specific transporter that 
is insensitive to glucose inhibition enabled the concurrent mixed-sugar utilization in 
Scheffersomyces stipitis, which played a crucial role to optimize the flux entering the 
highly regulated shikimate pathway located upstream of the AAA biosynthesis. Two 
novel quinate permeases isolated from Aspergillus niger were characterized to be capable 
of transporting shikimate to the co-cultured Saccharomyces cerevisiae strain that 
converted shikimate to the downstream AAA derivatives, norcoclaurine, with the highest 
titer (1,015 µg/L) ever reported in literature. Our work demonstrates the potential of 
microbial consortia platforms for the economical de novo synthesis of compounds from 





compartmentalization in different specialty strains allow effective fine-tuning and avoid 
intermediate buildup, leading to significant increased production. 
 
Keywords 
Glucose/xylose co-utilization, shikimate-pathway derivatives, Scheffersomyces stipitis, 
Saccharomyces cerevisiae, yeast consortia, plant secondary metabolites, xylose 




Plant-sourced aromatic amino acid (AAA) derivatives are a highly diverse group 
of compounds that is widely served as food additives, nutraceuticals, pharmaceuticals, 
and building blocks of drugs with considerable commercial values1. However, the 
production of these natural products in plants is tightly regulated, tissue-specific, and in 
the mixture with many structurally similar intermediates, leading to low yields and costly 
extraction processes2. Moreover, some plants that produce highly desired AAA 
derivatives  (i.e., Saussurea involucrata producing hispidulin, rutin, and syringin) are 
barely cultivable or even endangered3, 4. On the other hand, chemical synthesis is 
significantly retarded by the complex structures of AAA derivatives, which often posts 
stringent requirements for specific stereochemistry5. Accordingly, the development of 
synthetic microbial platforms as a surrogate for plant-based production of AAA 
derivatives has garnered tremendous attention. Most studies were performed in the model 





emphasis on the latter due to its amenability to the functional expression of endoplasmic 
reticulum (ER)-associated cytochrome P450s6 and complex post-translational 
modifications7.  
In recent years, successful production of numerous AAA-derived secondary 
metabolites including various flavonoids, stilbenoids, and benzylisoquinoline alkaloids 
(BIAs) in yeast highlights its potential as a chassis for the production of complex natural 
compounds. Koopman et al. reported the first de novo production of the exemplary 
flavonoid, naringenin, from L-tyrosine at a titer of 109 mg/L without the addition of 
expensive pathway intermediates8.  Further extension and modification of the naringenin 
pathway enabled the synthesis of additional flavonoid compounds, such as kaempherol, 
quercetin9, phloretin, nothofagin, and trilobatin10 in a range of 20-60 mg/L. The 
biosynthesis pathway of resveratrol, a natural polyphenol from the stilbenoid family, was 
also reconstituted in S. cerevisiae, and a stepwise metabolic engineering strategy enabled 
a final titer of 531.41 mg/L through a two-phase fed-batch fermentation11. Regarding the 
BIA branch, the complete biosynthesis of thebaine, hydrocodone12, and noscapine13 from 
simple sugar via coordinately expressing 20-30 enzymes originated from various species 
into S. cerevisiae represents two of the most important breakthroughs in building 
complex microbial synthetic platforms for the synthesis of plant-sourced natural 
products, although the production levels are merely at a few mg/L (noscapine) or even 
μg/L (thebaine and hydrocodone).  
The inefficient production is mainly caused by the distinctly different challenges 
present in individual modules of the pathways.  The upstream pathway is native to the 





employ sophisticated controls at both transcriptional and enzyme activity levels to 
minimize unnecessary energy expenditure in synthesizing aromatic amino acids14. For the 
downstream foreign add-on steps, it is not only challenging to functionally express 
combinations of genes sourced form plants, mammals, bacteria, and fungi, but also 
simultaneously balancing their expression levels, both among themselves and relative to 
the upstream enzymes because any impairment in the pathway will result in an 
intermediate buildup and thus, significantly decrease the final product yield. Specifically 
for the BIA pathways, in the past two decades, extensive efforts have been taken to (1) 
reduce enzyme promiscuity (e.g., the dopamine pathway)15, (2) create enzyme chimeras 
to avoid the incorrect processing and glycosylation occurring at the wrong compartment 
(e.g., the thebaine pathway)12, (3) reinforcing cofactor regeneration to improve the 
activities of cytochrome P450s and AAA hydroxylase (e.g., tetrahydrobiopterin in the 
melatonin and thebaine pathways)12, 16, 17, (4) pairing enzymes form multiple species 
(e.g., the sanguinarine pathway)18, (5) titrating gene copy number and spatially separating 
certain enzymes to intervene the side reaction (e.g., the morphine pathway)19, (6) 
optimizing enzyme activity (especially P450s) via testing promoters of not only different 
strengths but also various regulation patterns (e.g., the sanguinarine pathway)18. 
In the post CRISPR era, rapid advancement in the exploration of novel microbial 
species challenges the status of E. coli and S. cerevisiae as the classical microbial cell 
factories. Many nonconventional microorganisms are of great interest in a palette of 
industrial applications due to their innate traits with respect to the unique desirable 
physiology, biosynthetic, metabolic, and fermentation capacity, which are acquired 





upstream module of AAA biosynthetic pathways, our previous study demonstrated 7-fold 
higher production of shikimate in Scheffersomyces stipitis than S. cerevisiae22, because its 
active pentose phosphate pathway (PPP) renders a higher availability of erythrose-4-
phosphate (E4P), the rate-limiting precursor identified in S. cerevisiae23. The preliminary 
success in optimizing the upstream module suggests that S. stipitis could potentially serve 
as a better-suited host for the production of AAA derivatives. However, the current 
shortage of readily usable multi-auxotrophy, high-copy plasmids, and multiplex genome 
editing protocol for S. stipitis still hampers it from being a plug-and-play chassis. In 
addition, the aforementioned issues with respect to expressing challenging enzymes, ER 
stress, unrevealed competing pathways, and cofactor scarcity as encountered in S. 
cerevisiae will likely appear in the new host. 
While endeavoring to solve these issues specific to individual pathways and 
products, we have been attempting to build yeast consortia to leverage the highly active 
upstream module provided by S. stipitis and the extensively optimized downstream 
modules in S. cerevisiae (Figure 1). The breakthrough was enabled by the discovery of a 
novel xylose-specific transporter and two novel quinate permeases that shows high 
capability in transporting shikimate. Independent optimization of the two modules, 
efficient transfer of the connecting molecule, and easily adjustable ratio between the two 
species led to the production of the exemplary BIA, norcoclaurine, at 1,015 μg/L, which 
represents a 10-fold improvement over the best titer achieved by a S. cerevisiae 
monoculture15. This work highlights the advantages of using consortia in reconstituting 





platforms for the economical production of value-added plant-specialized natural 
products. 
 
4.2 Materials and Methods 
4.2.1 Strains and growth media 
S. cerevisiae YSG50 was used for in vivo plasmid construction via DNA 
assembler52-54. E. coli WM1788 or DH5α was used for the enrichment of all plasmids. S. 
stipitis FPL-UC7 was a gift from Dr. Thomas W. Jeffries (University of Wisconsin, 
Madison, WI)24. S. stipitis FPL-UC7 leu2Δ was derived from S. stipitis FPL-UC7 via the 
deletion of the gene encoding Leu2. S. cerevisiae BY4741 strain (MATa his3Δ1 leu2Δ0 
met15Δ0 ura3Δ0) was used for dopamine production. S. cerevisiae CEN.PK2-1C 
(MATa ura3-52 trp1-289 leu2-3,112 his3Δ1 MAL2-8C SUC2) was used for 
norcoclaurine production. All wild type yeast strains were grown in YPAD media 
containing 10 g/L yeast extract, 20 g/L peptone, 100 mg/L adenine hemisulfate, and 20 
g/L glucose unless otherwise noted. Yeast transformants were grown in synthetic 
complete (SC) media supplemented with amino acid mix (MP medicals, San Diego, CA), 
adenine hemisulfate, and appropriate carbon sources. A. niger, A. nidulans, and N. crassa 
were grown on YPAD plates and liquid minimal media as described elsewhere55, 56. All 
yeasts and fungi were cultured at 30°C with orbital shaking at 250 rpm unless otherwise 
noted. E. coli were selected in Luria-Bertani (LB) liquid media containing 100 mg/L 





4.2.2 RNA isolation 
A. niger, A. nidulans, and N. crassa were inoculated to 250 mL baffled shake 
flasks containing 20 mL minimal media plus 1 g/L shikimate as the sole carbon source 
for 5-day growth. Since A. niger grew better than the other two, it was chosen as the 
repository for shikimate transporter gene isolating, and the mycelia of A. niger was 
collected and frozen at -80°C for total RNA extraction. Briefly, the cell pellets of A. niger 
was first ground into powder in liquid nitrogen, followed by the isolation of total RNA 
using a RNeasy mini kit (Qiagen, Valencia, CA) and the removal of genomic DNA 
contamination using a Turbo DNA-free kit (Life Technologies, Carlsbad, CA). The 
purified total RNA was then reverse transcribed into cDNA libraries using a RevertAid 
first strand cDNA synthesis kit (ThermoScientific, Waltham, MA). 
4.2.3 Plasmid construction and yeast transformation 
All strains and primers used in this study were listed in Table S2. The genomic 
DNA (gDNA) of freshly grown S. stipitis FPL-UC7, S. passalidarum, Candida albicans, 
BY4741 was extracted using a Wizard genomic DNA purification kit (Promega, 
Madison, WI). The gDNA of Candia tropicalis, Candida parapsilosis, Candida 
guilliermondii, Candida tenuis, Debaryomyces hansenii was a gift from Dr. Huimin Zhao 
at University of Illinois Urbana Champaign. DNA fragments of xyl1, xyl2, xyl3, tal1, and 
tkt1, shortened promoters and terminators were amplified using the gDNA of S. stipitis 
FPL-UC7 as template. Each expression cassettes (SsENO1p-xyl1-SsGLN1t, SsGLN1p-
xyl2-SsAOX1t, SsOLE1p-xks1-SsUAGt, SsPIR1p-tkt1-SsOLE1t, SsTEF1p-tal1-
SsADH1t) were constructed via overlap extension PCR (OE-PCR)57, and assembled into 





were added between the ADH1p and TEF1t to facilitate rapid cloning of transporters. 
Plasmids carrying codon-optimized ScHXT11N366M58 and NcAN25R4.1830 for the 
expression in S. stipitis FPL-UC7 were prepared by Geneart Gene Synthesis 
ThermoFisher Scientific, Carlsbad, CA). DNA fragments encoding xylose transporters 
were amplified and co-transformed with the pMG-xyl linearized by AscI and XmaI (New 
England Biolabs, Ipswich, MA) into S. cerevisiae YSG50 for DNA assembly. The yeast 
plasmids were isolated using Zymoprep yeast plasmid Miniprep II (Zymo Research, 
Irvine, CA) followed by transformation to E. coli for plasmid propagation. QIAprep Spin 
Miniprep Kit (Qiagen, Valencia, CA) was used for E. coli plasmid isolation. The correct 
constructs were electroporated into S. stipitis FPL-UC7, and transformants were selected 
on the SC-ura plates for 3-6 days until colonies appeared. pMG-SA was derived from the 
previously reported pMG-SA7.3 through the replacement of ura3 selection marker with 
leu2 marker. 
All genes encoding quinate transporters were PCR amplified using the cDNA 
libraries of A. niger as template, and ScADH1p and ScCYC1t were cloned using the 
genomic DNA of BY4741 as template. These three fragments were purified using a 
Zymo Gel DNA Recovery Kit (Zymo Research, Irvine, CA) followed by the assembly to 
pRS413 linearized by ApaI and SalI using Gibson Assembly Cloning kit (New England 
Biolabs, Ipswich, MA). After preliminary screening, the best shikimate transporters, 
designated as AnQut1 and AnQut2, were codon-optimized and cloned into the multiple 
cloning sites of pRS413 along with ScADH1p and ScCYC1t. To increase the metabolic 






EcAroL-ScHXT7t, ScPGK1p-ScAro1-ScHXT7t) were built. The plasmid, p2249 (gift 
from Dr. John Deuber, University of Berkely, CA), were used as template to amplify the 
expression cassettes containing TyrH* encoding tyrosine hydroxylase and DODC 
encoding DOPA decarboyxylase15 (ScTDH3p-CYP76AD1*-ScTDH1t-ScCCW12p-
DODC-ScADH1t). The gene encoding a norcoclaurine synthase (NCS) variants from 
Coptis japonica with the first 24 amino acids deleted13 was synthesized from GenScript. 
For gene disruption in S. cerevisiae, DNA fragments containing the guide RNA 
and donor DNA ordered as gBlocks from Integrated DNA Technology (Coralville, IA) 
was seamlessly assembled into pCRCT plasmid using Golden Gate Assembly Kit. All 
primers were synthesized from Integrated DNA Technology (Coralville, IA) or DNA 
facility (ISU, Ames, Iowa). All restriction enzymes were purchased from Thermo Fisher 
Scientific (Waltham, WA) or New England Biolabs (Ipswich, MA). All cloned genes 
were sequence confirmed at DNA facility (ISU, Ames, Iowa) after cloning and before 
yeast transformation. All plasmid transformations of S. cerevisiae and S. stipitis were 
carried out via LiAc/Ss carrier DNA/PEG method59 and electroporation, respectively. 
After transformation, cells were grown on corresponding selective plates until colonies 
appeared. 
4.2.4 High cell density fermentation 
Recombinant S. stipitis strains carrying individual putative xylose-specific 
transporter were freshly grown on SC-ura plates for 3-4 days. Single colonies were 
inoculated to 250 mL baffled flasks (VWR, Chicago, IL) containing 50 mL SC-ura plus 
70 g/L glucose and 40 g/L xylose for seed culture preparation. The resulting cultures 





g/L glucose and 40 g/L xylose with initial OD600nm=10. Samples were taken every 24 h. 
Cell biomass was measured at OD600nm, and the sample supernatant was stored in -20°C 
freezer for later sugar concentration assay. Since the glycolysis pathway was not 
disrupted in the strain though we tried several times, high concentrations of mixed-sugars 
(70 g/L glucose and 40 g/L xylose) were used in HCDF to ensure that during the whole 
fermentation course glucose inhibition always existed and mimic the glucose/xylose ratio 
in lignocellulosic biomass hydrolysates. 
4.2.5 Ethanol and shikimate production in S. stipitis 
Recombinant S. stipitis strains were freshly grown on selective plates, and single 
colonies were inoculated to 250 mL baffled flasks (VWR, Chicago, IL) containing 20 mL 
SC-ura or SC-leu-ura plus 20 g/L glucose and 20 g/L xylose for seed culture preparation. 
For ethanol production, seed cultures were transferred to 100 mL serum bottles 
containing 60 mL fresh SC-leu-ura plus 28 g/L glucose and 12 g/L xylose with 250 rpm 
orbital shaking. For shikimate production, seed cultures were transferred to 250 mL 
baffled flasks containing 20 mL fresh SC-leu-ura plus different concentrations of 
glucose/xylose mixtures with 250 rpm orbital shaking. Initial cell OD600nm was ~0.2. 
Samples were taken every 24 h. Cell biomass was measured at OD600nm, and the sample 
supernatant was stored in -20°C freezer for sugar and metabolites test. 
4.2.6 Screening and characterization of shikimate transporters 
Plasmids harboring genes encoding putative shikimate transporters were 
transformed into BY4741, and transformants were grown on SC-his plates until colonies 
appeared. Five independent colonies of each transformation were first grown in SC-his 





(Fisher Scientific, Waltham, WA) containing 5 mL SC-his plus 40 g/L glucose and 1 g/L 
shikimate. After 72 h samples were taken and stored at -20°C for later shikimate usage 
assays. 
Plasmids containing the codon-optimized shikimate transporters, AnQut1co and 
AnQut2co, were transformed into BY4741, and transformants were grown on SC-his 
plates until colonies appeared. Three independent colonies were first grown in SC-his 
containing 20 g/L glucose until saturation, and then transferred to glass tubes (Fisher 
Scientific, Waltham, WA) containing 5 mL SC-his plus 40 g/L, 80 g/L, or 120 g/L 
glucose and 1 g/L shikimate with initial cell OD600nm~1 or 10. Samples were taken every 
24 h for cell OD600nm and shikimate usage assays. 
4.2.7 Norcoclaurine production 
For monocultures, single colonies of dopamine producing strains and 
norcoclaurine producing strains were prepared in SC-leu-his-ura media until saturation. 
Seed cultures were transferred to fresh SC-his-leu-ura media plus 60 g/L glucose, 5 g/L 
ascorbic acid and 1 g/L SA with initial cell OD600nm ~0.2. Samples were taken every 24 h 
for cell biomass and metabolite assays. 
For consortia, single colonies of SS-xyl-SpXUT1, the best norcoclaurine 
producing strain were prepared in SC-his-leu-ura media. Seed cultures were transferred to 
fresh SC-his-leu-ura media plus 60 g/L glucose, 20 g/L xylose, 5 g/L ascorbic acid and 1 
g/L SA with initial total cell OD600nm ~0.2. Due to the difference in cell growth rate, a 
series of cell ratio (e.g., Ss:Sc=9:1; 3:1; 1:1; 1:3; 1:9, 1:20, 1:40) were tested. Samples 





4.2.8 Analytical methods 
Shikimate was detected by Waters HPLC system (Waters, Milford, MA) as 
described elsewhere or by a colorimetric method as described elsewhere22, 60. Briefly, 100 
μL diluted samples were first oxidized by Solution 1 containing 0.5% periodate and 0.5% 
sodium m-periodate followed by 45 min incubation at 37°C. Then, the mixture was 
quenched by 100 μL Solution B (3:2 1 M NaOH/56 mM Na2SO3 (v/v)), and the 
absorbance at 382 nm was measured by a Synergy HTX multimode reader (Biotek, 
Winooski, VT).  
Dopamine and norcoclaurine was quantified by an Agilent UPLC coupled by a 
6540 UHD Q-TOF system (Agilent Technology) for fragmentation and mass detection. 
Samples were separated by the UPLC system equipped with a ZORBAX HILIC plus 
RRHD 2.1*100 mm-1.8 μm column (Agilent Technologies) with a flow rate at 0.4 
mL/min. Samples were eluted by a linear gradient from 100% mobile phase A (water 
plus 0.2% formic acid) to 100% mobile phase B (acetonitrile plus 0.2% formic acid) over 
the course of 9.7 min at 40°C. The Q-TOF system was run in a positive electrospray 
(ESI+) mode with a voltage of 150 V for fragmentation and a voltage of 23 V for MS/MS 
collision. For quantification of norcoclaurine, a retention time of 3.0-3.7 min and ion 
counts with m/z of 272.100 [M+H]+ were extracted. The DA and resveratrol standards 
were prepared using spent medium from BY4741 harboring empty plasmids. All samples 
were filtered through a 0.22-μm syringe filter (Simsii, Irvine, CA) prior to HPLC 
analysis. Shikimate, dopamine, and norcoclaurine standards were purchased from Sigma-






4.3.1 Refactoring the xylose utilization pathway to ameliorate the upstream flux 
The compartmentalization enabled by a consortium offers the opportunity to 
address the distinct issues arising from individual modules of a complex pathway. 
Previously, we have constructed a shikimate producing S. stipitis strain, which, prior to 
extensive optimization, outperformed any other yeast species with regard to the flux 
entering the upstream module of the AAA biosynthesis22. Considering that adequate 
evidence has demonstrated that the production of BIAs is primarily constrained by the 
downstream conversions, we hypothesized that a highly optimized upstream module 
established in S. stipitis would allow the expense of the nutrients in the co-culture in 
enriching the population of S. cerevisiae carrying the downstream module. 
S. stipitis is prominent for its superior native xylose-fermenting capacity. Since xylose is 
assimilated to the central metabolism through PPP, an improved simultaneous utilization 
of glucose and xylose will presumably ameliorate the availability of E4P, leading to a 
higher flux entering the AAA biosynthesis pathway. However, as a common issue 
encountered in many microbial hosts, the persistent carbon catabolite repression (CCR) 
severely prohibits microorganisms from efficiently assimilating xylose in the mixed-
sugar culture. To understand the cause of CCR, we performed RNA-seq analysis was of 
the S. stipitis strain grown in the cultures containing only glucose, only xylose, and the 
mixed sugars as the carbon sources. The cultures were sampled at 15, 48, and 72 hr, 
corresponding to the ‘prior glucose depletion’, ‘right after glucose depletion’, and ‘post 
glucose depletion’ stages in the mix-sugar culture (Figure S1a). The three genes in the 







Figure 1. Schematic of the S. stipitis/S. cerevisiae consortium that converted mixed 
sugars to dopamine and norcoclaurine. Abbreviations of metabolites: PEP, 
phosphoenolpyruvate; G6P, glucose-6-phosphate; Ri5P, D-ribulose-5-phosphate; X5P, 
D-xylulose-5-phosphate; R5P, ribose-5-phosphate; G3P, glyceraldehyde-3-phosphate; 
S7P, sedoheptulose-7-phosphate; F6P, fructose-6-phosphate; E4P, erythrose-4-phosphate;  
DAHP, 3-deoxy-D-arabinoheptulosonate 7-phosphate; 4-HPAA, 4-
hydroxyphenylacetaldehyde. Abbreviations of enzymes: xyl1, xylose reductase; xyl2, 
xylose dehydrogenase; xyl3, xylulokinase; tkt1, transketolase; tal1, transaldolase; Aro4*, 
feedback-resistant DAHP synthase mutant; Aro1, pentafunctional AROM protein; Aro7*, 
feedback-resistant chorismate mutase mutant; TyrH*, yeast active tyrosine hydroxylase; 
DODC, DOPA decarboxylase; NCS, norcoclaurine synthase. Dashed arrows indicate the 





















































(i.e., tkt1 and tal1) were identified to be significantly down-regulated in both the glucose 
and mixed-sugar conditions (e.g., by 3.8-56.3 folds at 15 h) (Table S1).  
To overcome this bottleneck, we constructed a plasmid, designated as pMG-xyl 
(Table S2 and Figure S2), replacing the native promoters of xyl1, xyl2, xyl3, tkt1 and tal1 
by strong constitutive promoters that were previously isolated from S. stipitis and 
insensitive to carbon sources22. The plasmid pMG-xyl was transformed into S. stipitis 
FPL-UC724 and high cell density fermentation (HCDF) was carried out for testing sugar 
usage of the resulting strain Ss-xyl (standing for S. stipitis carrying the refactored xylose 
pathway). In contrast to the strict CCR displayed by the strain carrying the wild type 
xylose pathway (designated as Ss-WT xyl), this engineered strain metabolized 4.4 g/L of 
xylose in the mixed sugars (70 g/L glucose and 40 g/L xylose initially) in 5-day 
fermentation (Figure 2a). This result demonstrated that CCR in S. stipitis could be 
partially attributed to the repressed transcription of the genes involved in intracellular 
xylose assimilation and other bottlenecks need to be tackled before. 
4.3.2 Discovery of novel xylose-specific transporters 
It is worth clarifying that for the compounds derived from the downstream 
module of the AAA pathway, incorporation of the xylose-utilization module is not based 
on the consideration that xylose-containing biomass could serve as a low-cost feedstock. 
Here, xylose pathway is added simply because of its positive influence on the landscape 
of carbon flux distribution that benefits the AAA upstream module. In fact, raw biomass 
hydrolysates should not be considered as the carbon sources as AAA derivatives are 





accounts for a significant portion to the overall production cost, especially when AAA 
derivatives are at low titers.  
The genome of S. stipitis harbors seven annotated xylose transporters, xut1-725. 
RNA-seq analysis indicated the transcription of the xylose transporter encoded by xut1 
was repressed in the presence of glucose (by 16.7 folds at 15 h) while all the other six 
transporters were barely transcribed under all three culturing conditions (Table S1). 
Nonetheless, we cloned each of these seven transporters downstream of a strong 
constitutive promoter into the plasmid pMG-xyl carrying the refactored xylose pathway. 
The results of HCDF showed that SsXUT1 and SsXUT2 improved xylose consumption 
to 11-16 g/L along with a co-utilization of 35-40 g/L glucose whereas the other five 
transporters only enabled marginal co-sugar utilization (Figure 2b and Figure S3). 
S. stipitis belongs to the CUG clade fungi, which reassign the CUG codon of 
leucine to serine. A vast majority of CUG clade yeasts possesses the native capability of 
xylose utilization (Table S3), and by virtue of this property, CUG yeasts have been 
serving as a repository for isolating genes involved in xylose uptake and metabolism for 
decades26. Among the CUG clade yeasts, Spathaspora passalidarum was reported as the 
mere yeast strain that co-utilizes glucose, xylose, and cellobiose27. We hypothesized that 
in S. passalidarum certain unexplored sugar transporters are responsible for xylose 
uptake during simultaneous mixed-sugar fermentation. Sequence alignment indicated that 
S. passalidarum contains three xylose transporters homologous to SsXUT1, SsXUT4, 
and SsXUT7 from S. stipitis. Moreover, previous transcriptome analysis of S. 
passalidarum indicated that the expression of another two hexose transporters encoded 








Figure 2. Metabolic engineering of S. stipitis for efficient glucose/xylose co-utilization. 
(a) Sugar utilization of Ss-WT xyl and Ss-xyl in SC-ura containing 70 g/L glucose and 40 
g/L xylose. (b) Screening of xylose specific transporters without glucose repression. Bars 
indicate xylose consumed and triangles indicate glucose remained after 5-day 
fermentation. The initial SC-ura containing 70 g/L glucose and 40 g/L xylose. 
Abbreviations: Ss, S. stipitis; WT, wild-type; Sp, Spathaspora passalidarum; Sc, 
Saccharomyces cerevisiae; Nc, Neurospora crassa. Error bars represents standard 
















































































































































the glucose-containing culture28. We incorporated each of these five S. passalidarum 
transporters into the plasmid pMG-xyl, followed by the transformation into S. stipitis 
FPL-UC7. As a result, the best strain Ss-xyl-SpXUT1 expressing XUT1 from S. 
passalidarum was capable of consuming 25 g/L xylose and 45 g/L glucose in the HCDF 
(Figure 2b). We also overexpressed ScHXT11N366T from S. cerevisiae29 and 
NcAN25R4.18 from Neurospora crassa30, both of which were previously reported to 
facilitate xylose transport into S. cerevisiae in the mixed sugars (Figure 2b), but the result 
showed that neither of them helped with xylose uptake in S. stipitis. Thus far, expression 
of efficient xylose-specific transporter in combination with promoter swapping for the 
genes involved in xylose conversion led to fully relieved CCR and simultaneous 
glucose/xylose utilization (Figure 3b). 
4.3.3 Removal of the CCR improved shikimate production in S. stipitis 
To test the shikimate-producing capability after mitigating the CCR, four 
shikimate producing S. stipitis strains (SA1-4) were constructed, among which SA1, 
SA2, and SA3 are control strains that carry the previously constructed plasmid pMG-SA 
harboring 3 genes responsible for shikimate accumulation in S. stipitis along with pMG-
xyl, pMG-SpXUT1, and pMG-eGFP (equivalent to an empty vector), respectively. All 
three-control strains accumulated extracellular shikimate at low levels ranging from 1.52 
to 1.92 g/L in the SC-leu-ura medium containing 28 g/L glucose and 12 g/L xylose. In 
contrast, the recombinant strain SA4, which harbored both pMG-xyl-SpXUT1 and pMG-
SA, produced 3.62 g/L shikimate under the same culture condition, representing at least 
88% higher than that of the control strains (Figure 3b). This also represents the highest 





than that of the most recently reported S. cerevisiae producer that have undergone much 
more extensively engineering31. To validate the hypothesis that increasing xylose 
concentration in the medium could further enlarge the flux towards E4P leading to an 
even higher shikimate titer, the four strains (SA1-4) were cultured in SC-leu-ura 
containing various concentrations of glucose and xylose. The highest shikimate titer was 




Figure 3. Fermentation profile and shikimate production after relieving CCR. (a) 
Fermentation profile of S. stipitis strain (Ss-xyl-SpXUT1) with relieved CCR in SC-leu-
ura plus 28 g/L glucose and 12 g/L xylose. (b) Shikimate production by S. stipitis strains 
in SC-leu-ura plus 28 g/L glucose and 12 g/L xylose. (c) Shikimate production by S. 
stipitis strains in SC-leu-ura plus 30 g/L glucose and 30 g/L xylose. Error bars represents 







































































than the titer of the best S. cerevisiae shikimate producing strain31, representing the 
highest level ever reported in yeasts. 
4.3.4 Discovering of novel transporters to enhance shikimate uptake in S. cerevisiae 
One of the prerequisites to build an efficient consortium is to enable the efficient 
metabolite transfer between the team players. At the initial stage, we did not recognize 
the transportation issue of shikimate to S. cerevisiae considering that shikimate is an 
endogenously produced metabolite that can be efficiently secreted to the medium. 
However, all the recombinant strains were incapable of uptake and consuming shikimate 
even when shikimate kinase AroL (cloned from E. coli) and the endogenous 
pentafunctional enzyme Aro1, both of which were reported to push the metabolic flux to 
the downstream conversion steps, were overexpressed32, 33 (Figure 4a). In some strains, 
we also included the overexpression of Aro7G141S, the chorismate mutase variant that 
catalyzes the reaction from chorismate to prephenate and resists feedback-inhibition 
posed by L-tyrosine34, with initial consideration. Moreover, neither of the codon-
optimized version of the two characterized shikimate transporters, E. coli ShiA35 and 
Corynebacterium glutamicum ShiA36 enabled improved shikimate uptake in S. cerevisiae 
(Figure 4b). Therefore, it was imperative to identify a novel shikimate transporter that 
can be highly and functionally expressed in S. cerevisiae. 
Thorough literature search back to 1970s returned the precious information that 
three fungi, Aspergillus niger, Aspergillus nidulans and Neurospora crassa were reported 
to have shikimate-assimilating capability37-39 but no specific studies regarding shikimate 
uptake was recorded. We grew the three fungi in minimal media containing shikimate as 





and N. crassa barely grew), which strongly indicated the existence of a highly functional 
shikimate transporting system in this fungus. On the other hand, quinate transporters have 
been studied in some fungi, such as A. nidulans40 and N. crassa41 and there were studies 
reporting that the bifunctional quinate/shikimate dehydrogenase accepts both shikimate 
and quinate as the substrate with a single binding site due to their structural similarities42, 
43 (Figure S3). Based on this information, we hypothesized that some quinate permeases 
might be capable of transporting shikimate. 
The sequence of the reported quinate permease (Qa-Y) from N. crassa41 was first 
used as the query to blast in the non-redundant protein sequence database of A. niger. A 
sequence (XP_001392502.1, designated as AnQut1) with the highest similarity (76%) to 
Qa-Y was pinpointed and used as the second query to re-blast the A. niger protein 
database. Seven additional putative quinate transporters (designated as AnQut2-8) were 
identified to share a similarity ranging from 50% to 78% (Table S3). Considering that all 
eight DNA sequences encoding putative quinate permeases harbored introns, we decided 
to clone the genes using cDNA libraries from A. niger cultivated in the medium using 
shikimate as the sole carbon source. Reverse transcription-PCR revealed the coding 
regions of seven putative quinate transporters (AnQut1-4, and 6-8), which were 
subsequently cloned into S. cerevisiae for shikimate uptake assay. Note that unlike A. 
niger, S. cerevisiae cannot use shikimate efficiently as the sole carbon source, and 
therefore the uptake assay was performed in the presence of sugar, which also mimicked 
the culture environment for the consortium to be established. Considering that S. stipitis 







Figure 4. Screening of shikimate transporters for efficient shikimate uptake by S. 
cerevisiae. (a) Shikimate utilization by S. cerevisiae strains with the overexpression of 
Aro7*, AroL, and/or Aro1 in 0.5 g/L shikimate after 3-day fermentation.  (b) Shikimate 
utilization of S. cerevisiae strains containing prokaryotic shikimate transporters and 
eukaryotic quinate permeases in 1 g/L shikimate after 3-day fermentation. (c) Shikimate 
utilization of S. cerevisiae strains harboring codon-optimized Aspergillus niger quinate 
permeases, AnQut1co and AnQut2co. Negative control contained the empty plasmid, 
pRS413. Media used were SC-his. Error bars represents standard deviations of five 
biological replicates. Abbreviations in figure: Cg, Corynebacterium glutaminum; Ec, 
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represents a smaller population than S. cerevisiae, shikimate was added to the media at a 
mock concentration of 1 g/L (as opposed to 4.5 g/L at the highest titer achieved by the 
optimized S. stipitis monoculture). Among the seven attained putative quinate 
transporters, AnQut1 and AnQut2 displayed significant higher shikimate transporting 
activity than all other five proteins and the negative control containing the empty plasmid 
(pRS413), with the corresponding strains consuming shikimate as high as 45% in 72-h 
fermentation (Figure 4b). To the best of our knowledge, these quinate permeases sourced 
from A. niger are the first two shikimate transporters functionally expressed in S. 
cerevisiae. To further improve the shikimate transporting activity, the codon-optimized 
versions of AnQut1 and AnQut2 were expressed in S. cerevisiae resulting in shikimate 
conversions ranging from 55% to 69% under optimal conditions (Figure 4c). 
4.3.5 Perplexing outcomes from applying ‘evident beneficial’ strategies 
Before bringing the shikimate-producing S. stipitis into the co-culture, the 
aforementioned manipulations (e.g., overexpression of AroL, Aro1 and Aro7G141S) were 
performed in the S. cerevisiae strain overexpressing AnQut1co to eliminate potential 
bottlenecks in the conversion of shikimate to the downstream products. Although these 
manipulations have been widely accepted as the beneficial strategies to enhance the 
production of AAA derivatives, their introduction in S. cerevisiae strain containing 
AnQut1co surprisingly caused decreased shikimate conversions (Figure 5a). 
To identify the issues, we dissected these manipulations and found that as long as 
AroL or the endogenous Aro1, was overexpressed, the shikimate conversion was strongly 
interrupted. In contrast, overexpression of Aro7G141S was beneficial to the shikimate 





overexpressing AnQut1co (Figure 5a). Further cell growth tests revealed that the 
introduction of Aro1 or AroL in S. cerevisiae strains containing AnQut1co impeded cell 
growth in the presence of shikimate (Figure S5). We reasoned that the reaction from 
shikimate to shikimate-3-phosphate (S3P) uses ATP as the cofactor and the overactive 
shikimate kinase thus drained the energy molecule in the presence of high-level 
shikimate, leading to poor cell propagation. Another possibility was the accumulation of 
intracellular S3P caused by overexpressed shikimate kinase would inversely repress the 
activity of shikimate kinase and exert inhibition on cell growth. 
4.3.6 Production of norcoclaurine 
BIAs are a structurally diverse family of plant-specialized L-tyrosine-derived 
compounds including more than 2,500 know structures. As the first committed backbone 
intermediate in the BIA pathway, norcoclaurine is synthesized via the condensation of 
dopamine and 4-hydroxyphenylacetaldehyde (4-HPAA) catalyzed by norcoclaurine 
synthase (NCS) (Figure 1). The two starter units, dopamine and 4-HPAA, are derived 
from a common precursor L-tyrosine. In yeast 4-HPAA is produced endogenously via 
Ehrlich pathway, whereas dopamine is exogenous and formed through sequential 
oxidation and decarboxylation that is catalyzed by tyrosine hydroxylase (TyrH) and L-
3,4-dihydroxyphenylalanine decarboxylase (DODC).  
In our design, the indigenous enzymes involved in the tyrosine-to-HPAA 
conversion remained untapped. We mainly focused on increasing the capacity of the 
three heterologous enzymes (e.g., TyrH, DODC, and NCS), and introduced three copies 
of TyrH*-DODC-NCS into CEN.PK2-1c resulting in NC3. The coculture of SA4 and 









Figure 5. Enhancing norcoclaurine production via multiple strategies. (a) Shikimate 
uptake by S. cerevisiae strains containing various combinations of downstream pathway 
genes. (c) Norcoclaurine production after removing Aro1 andAroL from S. cerevisiae 
strains and cocultures. Error bars represents standard deviations of three biological 
replicates. Enzymes: Aro7, chorismate mutase; AroL, shikimate kinase; Aro1, 




titers of norcoclaurine (Figure 5b).  Increasing the initial amount of NC3 in consortia is 
beneficial for the accumulation of norcoaclurine when Ss:Sc is high. The highest 
norcoaclurine titer from consortia was 1,015 µg/L, which is 10-fold higher than the titers 
reported in literature when S. cerevisiae monocultures were used. Further investigation 
should focus on relieve the metabolic load on the downstream strain and optimize the 
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The model host, S. cerevisiae, does not utilize xylose natively even after extensive 
evolutionary engineering44. Heterologous xylose utilizing pathways were introduced into 
S. cerevisiae to enable the xylose-utilizing capability, but due to CCR the recombinant S. 
cerevisiae strains prefers glucose over xylose in mixed-sugar culture. After extensive 
optimizations was carried out to enhance xylose pathways, the transport of xylose across 
cell membrane was recognized as an outstanding bottleneck. So far, most of the studies 
on xylose-specific transporters used S. cerevisiae EBY.VW4000 as a basal strain to 
screen xylose transporters without glucose inhibition (Table S4). However, due to the 
gene losses and chromosomal rearrangement during the concurrent knockout of 17 
hexose transporters, EBY.VW4000 obtained impaired sporulation- and germination-
capability and is only suitable for transporter characterization but not for industrially 
large-scale fermentation. Unlike S. cerevisiae, most CUG clade yeasts innately consume 
xylose (Table S5). Here in this study the best xylose-specific transporter, SpXUT1, 
isolated from S. passalidarum enabled mixed-sugar co-utilization in S. stipitis. After 
relieving CCR, the strain Ss-xyl-SpXUT1 produced the highest titer of ethanol, 15.30 
g/L, within 36 h, which was 29% and 24% higher than the titers provided by the two 
control strains. Moreover, the yield and volumetric productivity of ethanol by Ss-xyl-
SpXUT1 was 0.34 g/g sugar and 0.43 g ethanol/(h*L), representing 30% and 74% higher than 
those of the two control strains, respectively. These results validated that overcoming 
glucose repression is of great significance for efficient glucose/xylose conversion and 





Recently great interest has emerged in building synthetic microbial consortia for 
the production of high-value chemicals. The advantages of using a consortium is multi-
fold. Firstly, partitioning metabolic pathways in different specialist is beneficial for the 
optimal function and plug-and-play design. Terpenoids, also known as isoprenoids, are a 
large and diverse class of natural products with a multitute of applications. To overcome 
the incapability of E. coli to functional express cytochrome P450s (CYPs), Zhou et al. 
built a mutualistic consortium for the efficient production of oxygenated terpenoids via 
combining the rapid taxadiene-producing E. coli with S. cerevisiae that is amenable for 
the expression of CYPs. After a series of optimization, the microbial consortia produced 
33 mg/L oxygenated taxanes, which were barely detectable in either E. coli or S. 
cerevisiae monocultures that contained the entire pathway. Following the similar 
rationale, an E. coli consortia was developed and optimized for the efficient production of 
flavan-3-ols leading to a 970-fold improvement in titer over monoculture improvement45. 
Moreover, dividing long pathways in two members in the consortium can also reduce 
metabolic stress and at the same time offer a new perspective to balance pathway 
strength. For example, Ganesen et al. developed a naringenin-producing E. coli/E. coli 
consortium that accumulated more naringenin than the monoculture control46. The 
improved production was attributed to three factors, including alleviated metabolic 
burden, optimal host selection, and flexible pathway balancing (e.g., altering the ratio of 
the two members). Here, in this study S. stipitis was employed due to its superior xylose-
assimilating capability and active pentose phosphate pathway, while S. cerevisiae were 





plant-sourced secondary metabolites. The optimal environment for the functionality of all 
pathway enzymes did improved the final product titers.  
Regardless of the benefits of using microbial consortia for chemical production, 
one determinant of labor division in synthetic consortia is to realize effective metabolite 
transfer between sub-populations. Although some pathway intermediates (e.g., taxanene47, 
butyrate48, tyrosine and p-coumaric acid46) can be uptake by microorganisms, the re-
assimilation of other connecting molecules is impeded by the lack of efficient 
transportation system. Due to the low activity of the heterologous cis, cis-muconic acid 
(MA) synthesis pathway, 3-dehydroshikimic acid (DHS) was accumulated extracellularly 
in several monocultures that produce MA49, 50. A stable E. coli coculture system was 
constructed to facilitate the production of MA. In the consortia, one strain contained the 
upstream module that converted xylose to the intermediate, DHS; the other strain, which 
was glucose dependent, harbored the downstream module that converts DHS to MA. The 
discovery of a novel DHS transporter enabled the re-assimilation of extracellular DHS, 
which resulted in significantly higher yield (0.35 g sugar/g MA) than ever reported. In the 
current study, the entire BIA precursor synthesis pathway was split at the node of 
shikimate. Although shikimate is an endogenous metabolite of yeasts, the transport of 
shikimate is unidirectional, just like DHS. Therefore, two novel shikimate transporters 
were identified after extensively search to facilitate the efficient translocation of 
shikimate from media to S. cerevisiae. In this light, it is crucial to carefully pinpoint an 
appropriate transitional molecule to distribute pathways when designing consortia at the 





Although recent advances in synthetic biology and metabolic engineering have 
expedited our capability of manipulating microorganisms, synthetic microbial consortia 
are complex and dynamics systems making it hard to operate. More attention should 
focus on direct metabolic flux to target product globally in S. cerevisiae through 
strategies, for example, genome-scale engineering51.  
 
4.5 Conclusions 
To summarize, synthetic microbial consortia platforms were built for the efficient 
production of benzylisoquinoline alkaloids. The long metabolic pathways were split into 
two modules and allocated in S. stipitis and S. cerevisiae, respectively, for optimal 
function.  A novel xylose transporter free from glucose repression enhanced simultaneous 
glucose/xylose co-utilization resulting in enhanced shikimate production in S. stipitis. 
Two quinate permeases introduced into S. cerevisiae advanced the metabolite transfer 
between two yeasts. The production of norcoclaurine was 1,015 µg/L, representing the 
highest level ever reported in yeast. 
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4.7 Supplementary Information 
4.7.1 Supplementary tables  
Table S1. The differential expression of genes involved in xylose-utilization under 










Note: X, YPA+15 g/L xylose; G, YPA+35 g/L glucose; GX, YPA+35 g/L glucose and 15 g/L xylose.   
  XUT1 XYL1 XYL2 XYL3 TKT1 TAL1 
X/G 
15 h 16.7 34.7 7.3 56.3 3.8 5.6 
48 h 18.8 14.0 2.2 5.3 1.8 2.1 
72 h 1.2 0.2 0.2 0.3 0.5 0.4 
X/GX 
15 h 15.0 21.3 7.0 9.7 4.0 4.2 
48 h 15.4 1.0 0.7 0.6 1.0 0.8 





Table S2. Strains and plasmids constructed in this study. 
 
Strains or plasmids Description Reference 
Strains 
S. cerevisiae YSG50 
MATα, ade2-1, ade3Δ22, ura3-1, his3-11, 15, trp1-1, leu2-3, 112, 
and can1-100 
1 
S. stipitis FPL-UC7 NRRL Y-21448, ura3-3 2 
S. stipitis FPL-UC7 leu2Δ ura3-3, leu2-2 Unpublished data 
BY4741 MATa, his3Δ1, leu2Δ0, met15Δ0, ura3Δ0  
CEN.PK2-1c MATa ura3-52 trp1-289 leu2-3,112 his3Δ1 MAL2-8C SUC2  
Ss-xyl S. stipitis FPL-UC7, pMG-xyl This study 
Ss-xyl-SsXUT1 S. stipitis FPL-UC7, pMG-xyl-SsXUT1 This study 
Ss-xyl-SsXUT2 S. stipitis FPL-UC7, pMG-xyl-SsXUT2 This study 
Ss-xyl-SpXUT1 S. stipitis FPL-UC7, pMG-xyl-SpXUT1 This study 
Ss-SpXUT1 S. stipitis FPL-UC7, pMG-SpXUT1 This study 
Ss-xyl-ScHXT11N366T S. stipitis FPL-UC7, pMG-xyl-ScHXT11N366T This study 
Ss-xyl-NcAN25R4.18 S. stipitis FPL-UC7, pMG-xyl-NcAN25R4.18 This study 
SA1 S. stipitis FPL-UC7 leuΔ-pMG-xyl, pMG-SA This study 
SA2 S. stipitis FPL-UC7 leuΔ-pMG-SpXUT1, pMG-SA This study 
SA3 S. stipitis FPL-UC7 leuΔ-ARS/CEN5-750bp-eGFP, pMG-SA This study 






ARS/CEN5-750bp-eGFP URA3, a centromeric plasmid 3 
pMG-xyl 
ARS/CEN5-750bp, SsADH1p-SsTEF1t, SsENO1p-xyl1-SsGLN1t, 
SsGLN1p-xyl2-SsAOX1t, SsOLE1p-xyl3-SsUAGt, SsPIR1p-tkt1-
SsOLE1t, and SsTEF1p-tal1-SsADH1t 
This study 
pMG-xyl-SsXUT1 pMG-xyl-SsADH1p-Ssxut1-SsTEF1t This study 
pMG-xyl-SsXUT2 pMG-xyl-SsADH1p-Ssxut2-SsTEF1t This study 
pMG-xyl-SpXUT1 pMG-xyl-SsADH1p-Spxut1-SsTEF1t This study 
pMG-SpXUT1 ARS/CEN5-750bp-SsTEF1p-Spxut1-SsTEF1t This study 
pMG-xyl-ScHXT11N366T pMG-xyl-SsADH1p-Schxt11N366T-SsTEF1t This study 
pMG-xyl-NcAN25R4.18 pMG-xyl-SsADH1p-NcAN25R4.18-SsTEF1t This study 
pMG-eGFP 












Table S3. Information of eight selected quinate permeases for testing shikimate uptake. 















AnQut1 1 XP_001392502.1 535 100 100 
AnQut2 2 XP_001399921.1 536 64 78 
AnQut3 2 XP_001401052.1 518 36 56 
AnQut4 3 XP_001396962.2 543 33 53 
AnQut5 4 XP_001395243.2 534 34 51 
AnQut6 3 XP_001398629.1 553 31 52 
AnQut7 11 XP_001394918.2 566 33 50 





Table S4. Current work on xylose transporter without glucose repression in yeast. 
Transporter expression host Protein or module Mutated site Transporter origin Test in non-deficient strain References 
EBY.VW4000 G-G/F-XXX-G -- C. intermedia   
S. cerevisiae 
No 4 
EBY.VW4000 (CEN.PK2-1C) GAL2 N376F S. cerevisiae No 5 
EBY.VW4000 (CEN.PK2-1C) HXT7 N370S S. cerevisiae No 5 
Sc DS71054 HXT36 N367A S. cerevisiae No 6 
EBY.VW4000 AN25R4.18 
 
S. cerevisiae No 7 
JBEI_ScMO001 HXT7 F79S S. cerevisiae JBEI_ScMO001 8 
EBY.VW4000 Xyp29 
An25 
-- S. stipitis 
N. crassa 
No 9 
Sc DS71054, Ds68625 HXT11 N366T (N366M) S. cerevisiae No 10 




C. intermedia  
S. stipitis 
Sc FPL-YSX3  11 
EBY.VW4000 36 transporters -- Multiple origins No 12 
EBY.VW4000 without HXK1, 
HXK2, GLK1 
 




M40V, truncation in C-terminal tail 
 No 13 
 
Note: The EBY.VW4000 strain has a concurrent knockout of 18 sugar transporters including HXT1-17 and GAL2. JBEI_ScMO001, a BY4742 strain with the 
deletion of the xylose reductase, gre3, and the overexpression of the Piromyces sp. xylose isomerase, pspXI, and xylulose kinase. The strain, BY4742, does not 
grow on xylose. DS68625 contains a xylose-fermenting pathway but lacks the HXT1-7 and GAL2 genes and therefore cannot grow on xylose, while it grows 








Table S5. Xylose assimilating ability of CUG clade yeasts, and the max identity of 
their protein with SpXUT1. 
 
Microorganism Xylose-assimilating ability Max identity (%) 
Spassaspora passalidarum yes 100 
Scheffersomyces stipitis yes 79 
Candida albicans yes 67 
Candida dubliniensis Only 5% assimilate xylose  67 
Candida maltosa yes 67 
Candida tropicalis yes 66 
Candida tenuis yes 56 
Candida guilliermondii yes 41 
Candida auris no 39 
Debaryomyces hansenii yes 37 
Lodderomyces elongisporus yes 37 
Candida tanzawaensis no 36 
Hyphopichia burtonii yes (weak) 34 
Canada lusitaniae yes 34 
Metschnikowia bicuspidata some yes, some no 34 
Candida orthopsilosis yes 32 
Candida parapsilosis yes 32 
Metschnikowia fructicola yes (weak) -- 
Meyerozyma caribbica yes -- 
Spassaspora arborariae yes -- 
Candida oleophila yes -- 
Candida sojae yes -- 
 
Note: --, no genome sequence is available or no significant similarity found. All data 
about xylose-assimilating ability are collected from National Collection of Yeast 













(g ethanol/g sugar) 
Productivity 
g ethanol/(h*L) 
Ss-xyl 11.58 0.26 0.24 
Ss-SpXUT1 11.78 0.27 0.25 







Table S7. Primers used in this study.  
 






















































































































































































































4.7.2 Supplementary figures  
Figure S1. The growth and sugar consumption of S. stipitis cultured in YPA plus 3.5% 
glucose (a), YPA plus 3.5% glucose and 1.5% xylose (b), and YPA plus 1.5% xylose (c).  
Initial OD600 was at ~0.2.  Error bars represent the standard deviations of four replicates. 
This figure was from Gao et al., 2017 ACS Synth. Biol16.  
 

















Figure S3. The chemical structures of quinate and shikimate. 
  




Figure S4. The growth curves of S. cerevisiae strains containing ScAro7*, ScAro1, 































Figure S5. The performance of xylose transporters from other CUG yeasts. The 
recombinant S. stipitis FPL-UC7 strains containing each of the transporters was cultured 
in SC-Ura plus 70 g/L glucose and 40 g/L xylose with initial OD600nm=10. The S. stipitis 
FPL-UC7 strain carrying the plasmid pMG-xyl was used as control. Abbreviations: Cp, 
Candida parapsilosis; Cg, Candida guilliermondii; Ctr, Candida tropicalis; Ct, Candida 
tenuis; Ca, Candida albican; and Dh, Debaryomyces hansenii. Error bars represent 
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CHAPTER 5 FUTURE PERSPECTIVES AND CONCLUSIONS 
Over the past two decades, technologies arising from synthetic biology and 
systems biology have revolutionized metabolic engineering to establish bio-based 
production using engineered microorganisms. The shikimate biosynthesis pathway, 
together with its downstream branches, represents one of the most valuable biosynthetic 
pathways. The products derived from this pathway range widely, from various high-
volume low-value commodity chemicals to the realm of specialty chemicals and complex 
natural products1-3. 
The pathways leading up to the synthesis of aromatics are ubiquitous in all 
microorganisms, constituting the backbone reactions for the synthesis of a diverse class 
of compounds. The model hosts Escherichia coli and Saccharomyces cerevisiae have 
been manipulated to produce this group of compounds in most studies, but other species 
such as Scheffersomyces stipitis, Pseudomonas putida, and Corynebacterium glutamicum 
have also been engineered as production hosts, and in many cases, they outperform 
model hosts thanks to their special biochemical and metabolic features. 
The downstream pathways beyond the biosynthesis of the three aromatic amino 
acids open a treasure trove of molecules with extremely diverse structures and high 
values, the majority of which are produced by plants. These natural products encompass a 
billion-dollar market4-7, but their extraction from plant tissues requires immense 
quantities of biomass and cumbersome separation processes. Open-field plant growth and 
the associated costs are also susceptible to environmental factors, which are associated 







chemistry involved in forming these aromatics makes their de novo chemical synthesis 
very challenging and economically unviable at commercial scales. The implementation of 
microbial factories, engineered with heterologous biosynthetic pathways, represents an 
encouraging solution to these problems. It potentially ensures sustainable and greener 
processes with higher yields, and also enables further derivatization for new drug 
development. Unlike the biosynthesis of the high-volume low-value chemicals, which has 
been attempted in various microbial hosts, strain engineering to produce these plant-
derived natural products has been extensively performed in E. coli and S. cerevisiae. 
Between these two hosts, S. cerevisiae also has the advantage of expressing membrane-
associated eukaryotic enzymes (e.g., cytochrome P450s), which are required for the 
synthesis of some complex natural products derived from plants8, 9. 
 
5.1 Advanced Strategies and Future Prospects 
Despite their importance, the current production levels for aromatic compounds 
based on microbial hosts are quite low. To enable high-level biosynthesis of aromatic 
compounds, especially, those plant-derived natural products whose synthesis typically 
requires 20–30 enzymatic reactions, the most effective strategies would be (1) 
partitioning a complex pathway into smaller modules, (2) independently addressing the 
outstanding issues arising from individual modules, and (3) overcoming the obstacles to 
connecting modules. This is because distinctly different challenges are recognized in 
individual parts of a pathway. Any impairment in the pathway will cause an intermediate 
buildup, thereby considerably decreasing the final product yield. The upstream pathway 







therefore, the host employs sophisticated controls to minimize unnecessary energy 
expense10-13. For the downstream foreign add-on steps, heterologous expression poses the 
major limitation14. Many plant-sourced enzymes are so delicate that the alteration of the 
intracellular expression environment would impair their functions. The modular design 
approach enables researchers to reach an optimal balance by searching a relatively small 
combinatorial space, and using delicate “design-build-test-learn” cycles to improve the 
production by thousands of times over the starting levels (e.g., 15,000-fold improvement 
in taxol production15). 
To optimize the upstream module, besides the targeted rational strategies that 
have been widely used in previous studies, directed evolution-based genome-scale 
engineering could be considered to enhance the production. The intrinsically complicated 
regulations involved in the native upstream module prohibit the extra energy expenditure 
to create “foreign” molecules. With the rapid development of the CRISPR-associated 
technologies (e.g., CRISPR activation and CRISPR interference), creating a library 
including both upregulation and downregulation at the genome scale is now feasible. This 
platform would enable the modulation of gene expression within its native genome 
context, bypassing the need to utilize heterologous or synthetic promoters. Rather than 
limiting the system to an “on” or “off” state (i.e., overexpression or deletion), it can 
provide a platform in which genes can be studied in a wide range of transcriptional 
strengths. This property enables the creation of “fluidic” genetic landscapes that 
otherwise would not be possible by single gene deletion or overexpression (e.g. the 
glycolytic genes). Molecular sensors16, 17 to detect the final product or the intermediates 







Success has been demonstrated in the colorimetric reaction for detecting L-DOPA17 and 
the fluorescence protein-based naringenin sensor80. In addition, the current repertoire of 
microbial hosts needs to be broadened. Some nonconventional microbes possess the 
special biochemical and physiological features that are beneficial to the production of 
aromatic amino acid pathway derivatives. Genome-scale transcriptome programming 
integrated with high-throughput screening might be the most desirable technology to 
further deepen the understanding of non-model organisms. 
For the downstream module, ensuring successful gene expression in heterologous 
hosts is a complex process, without general rules to follow. It is impossible to accurately 
predict the rate-limiting steps when expressing enzymes from a wide variety of sources. 
A consensus drawn from pioneering work in opioid18, 19, artemisinic acid20-22, and taxol14, 
15 production is that it is important to explore the functional space defined by the natural 
sequence diversity23; in each of these three platforms, a suite of enzymes from mammals, 
plants, bacteria, and fungi were assembled and tested to determine an optimal 
combination. Moreover, P450 requires a partner enzyme, CPR to shuttle electrons9, and 
in some cases P450 also requires interaction with cytochrome b5, which provides 
additional redox support to achieve full activity21, 24, 25. Sufficient evidence has indicated 
that it is not necessary to match P450 with the CPR from the same species; pairing 
multiple species-sourced enzymes has led to better turnovers21, 23.   
Expressing membrane-bound enzymes can induce endoplasmic reticulum stress 
response because these enzymes have N-terminal signal peptides that are directly inserted 
into the endoplasmic reticulum23, 26, 27. In some cases, altering the expression level of 







between these two proteins can result in the release of reactive oxygen species, which 
reduce cell viability21, 28-30. Besides, the overexpression of multiple P450s could cause 
heme depletion, which can further induce cellular stress. In this scenario, a strategy of 
overexpressing the rate-limiting enzymes in the endogenous heme biosynthesis should be 
considered, which has been shown to successfully alleviate such a stress31.   
Finally, but very importantly, streamlining the performance of a process involving 
more than 20 steps requires the coordination of the corresponding genes. Synthesizing a 
desired compound often creates competition with cell growth, in which case, being able 
to easily fine-tune the expression of individual genes is essential. This might be achieved 
by varying promoter strength, integrating additional copies of the rate-limiting step, and 
adjusting the temperature to optimize enzyme activity15, 23, 32, 33. Once a high-production 
strain is established in shaking flasks, the production can be continuously improved in a 
bioreactor. By adjusting parameters such as temperature, pH, oxygen level, and sugar-




Microbial production of plant-sourced secondary metabolite is a promising 
alternative to the current plant-based extraction due to its sustainability and ease to 
control. Although model hosts are extensively used in the production of plant-sourced 
chemicals, the titers remain low and need to be further improved before 
commercialization. Looking beyond model hosts, many non-conventional yet poorly 







tolerance to extreme heat and salt, and high protein excretion mechanism) that is difficult 
to be horizontally transferred. Expanding the current collection of microbial organisms 
and taking advantage of these unique properties open up a new direction in developing 
microbial platforms for the production of industrial high-value chemicals. 
In yeasts, the condensation of phosphoenolpyruvate (PEP) and erythrose-4-
phosphate (E4P) is the first committed step in the shikimate pathway, from which all 
aromatics is derived from. Thus, it is of significance to increase metabolic flux at this 
valve. Due to the innate difference of glycolysis and pentose phosphate pathway, the 
availability of PEP and E4P in microorganisms is neither abundant nor at a balanced 
ratio. Therefore, it is important to enhance the intracellular concentration of these two 
precursors. 
The metabolic pathways for de novo synthesis of plant sourced-aromatics are 
usually very long and sometimes could be 20-30 steps, thus the re-constitution of the 
whole pathways in single organisms will lead to excess metabolic load and any stepwise 
loss will result in low titers of final product. Unlike monocultures, microbial consortia 
distribute metabolic stress to its sub-populations and can also provide optimal cellular 
environment for the function of pathway enzymes. However, the complex and dynamic 
coculture design also brings in new challenges, such as metabolites transfer and 
channeling, system stability, and mutual inhibitory effect. To increase the real industrial 
applications of microbial consortia, new technologies must be developed. For example, 
biosensors can be used to monitor and control the team players in a consortium in a real-
time manner. Moreover, computational models of consortia can be used as a guide to 







The conclusions of this dissertation are summarized as follows: 
• The exploration of non-conventional yeasts, especially those possess 
highly desirable metabolic and physiological traits yet to be analyzed and 
studied, opens up new alternatives for the development of efficient 
industrial biocatalysts. 
• Platform technologies, like RNA-seq, are useful in the development of 
genetic manipulation tools (e.g., promoters and terminators), which serves 
as prerequisites in metabolic engineering non-conventional yeasts. 
• Precursor availability is crucial in pushing metabolic flux to a target 
metabolic pathway. Especially when more than one precursor is involved, 
increasing the abundance of the insufficient ones would be beneficial. 
• Both the inhibited gene transcription and preferred glucose transportation 
resulted in the strict carbon catabolite repression (CCR) in yeasts. The 
only effective way to relieve CCR is to activate both levels 
simultaneously. 
• Due to the intrinsic complexity of regulatory networks that regulate cell 
functions in yeasts, genome-scale engineering strategies should be applied 
to achieve efficient and economical production of target compounds. 
• Synthetic consortium systems that integrate the advantages of each 
member and distribute metabolic burden of long pathways to subunits 
represents a promising approach in accomplishing complex tasks. Future 







• Regarding the metabolic burden caused by the overexpression of pathway 
genes, the discovery of high active pathway enzymes or synthetic 
pathways is favorable in effective production of plan-sourced aromatic 
amino acid derivatives. High throughput screening methods need to be 
generated to accelerate the whole process. 
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